Top 15 Differential Diagnosis for a 70-year-old male, with typical or atypical symptoms of abdominal pain,vomiting,bloody diarrhea,leukocytosis,elevated lactate
| Feature | Detail |
|---|---|
| Mechanism | SMA embolism (cardiac source — AF, MI) or atherosclerotic thrombosis |
| Classic presentation | Pain out of proportion to physical exam; nausea, vomiting, bloody diarrhea |
| Lab pattern | Leukocytosis, markedly elevated lactate, metabolic acidosis, elevated LDH |
| Risk factors | AF, atherosclerotic disease, prior cardiac events (common in 70-year-old males) |
| Hallmark | "Pain out of proportion to findings" early; peritonitis + septic shock late |
| Key test | CT angiography of mesenteric vessels |
| Pitfall | Physical exam can be deceptively benign early — do not be reassured by soft abdomen |
"An elderly patient with bloody diarrhea and abdominal pain out of proportion to the physical examination may have mesenteric ischemia — a true emergency." — Tintinalli's Emergency Medicine
"Sudden onset of abdominal cramps in patients with underlying cardiac or atherosclerotic disease, often associated with bloody diarrhea." — Schwartz's Principles of Surgery
| Feature | Detail |
|---|---|
| Mechanism | Non-occlusive hypoperfusion of watershed zones (splenic flexure, rectosigmoid) |
| Presentation | Crampy LLQ pain, bloody diarrhea (often maroon/bright red), low-grade fever |
| Lab pattern | Leukocytosis, elevated lactate (15% severe cases), metabolic acidosis, elevated LDH |
| Risk factors | Atherosclerosis, CHF, hypovolemia, post-aortic surgery |
| Key test | CT abdomen + pelvis (colonic wall thickening, thumb-printing); colonoscopy |
"In severe cases: intense abdominal pain out of proportion to clinical exam, leukocytosis, metabolic acidosis, elevated lactate — mortality 15%." — Yamada's Textbook of Gastroenterology
| Feature | Detail |
|---|---|
| Classic triad | Sudden severe abdominal/back pain + hypotension + pulsatile mass |
| Atypical presentations | Can present with hematochezia (aortoenteric fistula), vomiting, referred flank/groin pain |
| Lab pattern | Anemia, elevated lactate, leukocytosis from hemodynamic stress |
| Risk factors | Age >65, male sex, smoking, hypertension |
| Key test | Bedside ultrasound (rapid), CT angiography if stable |
"Back or abdominal pain is the most common presenting symptom... the classic triad of a leaking/ruptured AAA." — Tintinalli's Emergency Medicine
| Feature | Detail |
|---|---|
| Mechanism | Adhesions, hernia, volvulus → venous congestion → ischemia → necrosis |
| Presentation | Crampy abdominal pain, vomiting (feculent), obstipation, distension; bloody diarrhea when strangulation occurs |
| Lab pattern | Leukocytosis, elevated lactate (ischemia marker), metabolic acidosis |
| Risk factors | Prior abdominal surgery, hernias, malignancy |
| Key test | CT abdomen (transition point, free air, pneumatosis) |
"Obstruction leads to vomiting, extravascular fluid accumulation, strangulation and necrosis of bowel may occur." — Rosen's Emergency Medicine
| Feature | Detail |
|---|---|
| Presentation | Sudden abdominal distension, crampy pain, vomiting, obstipation; bloody output if ischemic |
| Lab pattern | Leukocytosis, lactate elevation if ischemia/necrosis develops |
| Risk factors | Elderly, chronic constipation, neuropsychiatric illness, nursing home residence |
| Key test | Plain X-ray (coffee-bean sign for sigmoid); CT confirms |
| Management | Flexible sigmoidoscopy (sigmoid) or emergent surgery if cecal |
| Feature | Detail |
|---|---|
| Presentation | Sudden onset severe generalized abdominal pain, peritonitis, vomiting; may have bloody stool |
| Lab pattern | Marked leukocytosis, elevated lactate (septic shock physiology), elevated CRP |
| Key test | CT abdomen (free air under diaphragm), upright CXR |
| Feature | Detail |
|---|---|
| Presentation | LLQ pain (can be diffuse), fever, leukocytosis; rectal bleeding if abscess tracks |
| Lab pattern | Leukocytosis, elevated lactate if septic |
| Risk factors | Previous uncomplicated diverticulitis, low-fiber diet, NSAID use |
| Key test | CT abdomen/pelvis with IV contrast |
"Most patients present with left-sided abdominal pain, with or without fever and leukocytosis." — Schwartz's Principles of Surgery
| Feature | Detail |
|---|---|
| Presentation | Sudden epigastric pain, vomiting; older patients may lack classic peritoneal signs ("silent perforation") |
| Lab pattern | Leukocytosis, elevated lactate (septic peritonitis), elevated amylase |
| Risk factors | NSAID/aspirin use (very common in this demographic), H. pylori, steroids |
| Key test | Upright CXR (free air), CT abdomen |
| Feature | Detail |
|---|---|
| Presentation | Profuse watery or bloody diarrhea, abdominal pain/distension, fever, colonic ileus |
| Lab pattern | Marked leukocytosis (WBC >15,000; >50,000 in fulminant), elevated lactate, hypoalbuminemia |
| Risk factors | Recent antibiotics, PPI use, hospitalization, age >65, immunosuppression |
| Fulminant features | Septic shock, organ failure, toxic megacolon, ileus (no diarrhea despite disease) |
| Key test | Stool PCR/GDH/toxin assay; CT (colonic wall thickening, "accordion sign") |
"Abdominal pain, peritoneal signs, colonic dilatation, marked leukocytosis, and a clinical picture of progressive sepsis with elevated serum lactate and end-organ failure." — Sleisenger & Fordtran's GI Disease
| Feature | Detail |
|---|---|
| Presentation | Bloody diarrhea, fever, crampy abdominal pain, vomiting |
| Lab pattern | Leukocytosis, elevated lactate (severe/septic), elevated CRP |
| Risk factors | Food exposure (recent travel, undercooked meat, raw produce), immunosuppression |
| Special concern | EHEC O157:H7 → HUS (microangiopathic hemolytic anemia, thrombocytopenia, AKI) |
| Key test | Stool cultures, PCR GI panel, CBC + metabolic panel |
| Feature | Detail |
|---|---|
| Fulminant criteria | >6 bloody stools/day + ≥1 of: fever >37.8°C, HR >90, Hgb <10.5, ESR >30 |
| Lab pattern | Leukocytosis, elevated lactate (toxic megacolon/sepsis), hypoalbuminemia, anemia |
| Key test | CT abdomen (colonic dilation >6 cm = toxic megacolon), flexible sigmoidoscopy |
| Risk factors | Known IBD, NSAID/antibiotic trigger, new diagnosis |
| Feature | Detail |
|---|---|
| Presentation | Generalized abdominal pain, fever, vomiting; bloody diarrhea if colonic source |
| Lab pattern | Leukocytosis, elevated lactate (sepsis/septic shock criteria), elevated CRP/procalcitonin |
| Sources | Diverticular abscess, hepatic abscess, post-op leak, cholecystitis with perforation |
| Key test | CT abdomen with IV contrast; blood cultures |
"Most patients have fever, leukocytosis, and abdominal pain, but frequently there are no localizing signs or symptoms." — Murray & Nadel's Respiratory Medicine (on intra-abdominal abscess)
| Feature | Detail |
|---|---|
| Presentation | Subacute or acute obstruction with vomiting; hematochezia; can perforate |
| Lab pattern | Leukocytosis (if perforated/obstructed), elevated lactate, anemia, elevated CEA |
| Risk factors | Age, male, family history, prior polyps, low-fiber diet |
| Key test | CT abdomen/pelvis, colonoscopy when stable |
| Feature | Detail |
|---|---|
| Presentation | Subacute diffuse abdominal pain, vomiting, bloody diarrhea (when infarction occurs) |
| Lab pattern | Leukocytosis, elevated lactate (late/infarction), hypercoagulable workup abnormal |
| Risk factors | Portal hypertension (cirrhosis), malignancy, thrombophilia, polycythemia vera |
| Key test | CT angiography (venous phase) — thrombus in portal/SMV |
| Feature | Detail |
|---|---|
| Presentation | Epigastric pain radiating to back, vomiting, abdominal tenderness; can have paralytic ileus with diarrhea |
| Lab pattern | Elevated lipase/amylase, leukocytosis, elevated lactate (severe/necrotizing), elevated LDH |
| Risk factors | Gallstones (#1 in elderly), alcohol, hypertriglyceridemia, medications |
| Key test | CT abdomen with IV contrast (Balthazar scoring), lipase, LFTs |
| # | Diagnosis | Pain | Bloody Diarrhea | Leukocytosis | Elevated Lactate | Priority |
|---|---|---|---|---|---|---|
| 1 | Acute Mesenteric Ischemia (SMA) | ✅ Out of proportion | ✅ | ✅ | ✅✅ High | 🔴 Critical |
| 2 | Ischemic Colitis | ✅ LLQ | ✅ Maroon | ✅ | ✅ (severe) | 🔴 Critical |
| 3 | Ruptured AAA | ✅ Back/abd | ✅ (fistula) | ✅ | ✅ | 🔴 Critical |
| 4 | Strangulated Obstruction | ✅ Crampy | ✅ Late | ✅ | ✅ | 🔴 Critical |
| 5 | Sigmoid/Cecal Volvulus | ✅ | ✅ Late | ✅ | ✅ Late | 🟠 Urgent |
| 6 | Colonic Perforation | ✅ Severe | ✅ Variable | ✅✅ | ✅ | 🟠 Urgent |
| 7 | Complicated Diverticulitis | ✅ LLQ | ✅ Variable | ✅ | ✅ Septic | 🟠 Urgent |
| 8 | Perforated PUD | ✅ Epigastric | ± | ✅ | ✅ | 🟠 Urgent |
| 9 | Fulminant C. diff Colitis | ✅ | ✅✅ | ✅✅ Marked | ✅ Fulminant | 🟡 High |
| 10 | Severe Infectious Colitis | ✅ Crampy | ✅✅ | ✅ | ✅ Septic | 🟡 High |
| 11 | Acute Severe UC / Toxic Megacolon | ✅ | ✅✅ | ✅ | ✅ | 🟡 High |
| 12 | Abdominal Sepsis / Peritonitis | ✅ | ✅ Variable | ✅✅ | ✅✅ | 🟡 High |
| 13 | Colorectal Cancer + Complication | ✅ | ✅ | ✅ (if perforated) | ✅ | 🟡 High |
| 14 | Mesenteric Venous Thrombosis | ✅ Diffuse | ✅ Late | ✅ | ✅ Late | 🟡 High |
| 15 | Severe/Necrotizing Pancreatitis | ✅ Epigastric | ± | ✅ | ✅ (organ failure) | 🟡 High |
| Study | Targets |
|---|---|
| CT Abdomen/Pelvis with IV contrast | AMI, AAA, volvulus, perforation, diverticulitis, malignancy |
| CT Angiography (mesenteric) | AMI, MVT, aortic emergency |
| Bedside ultrasound (FAST/RUSH) | AAA, free fluid, cardiac function |
| Labs: CBC, BMP, lactate (serial), LFTs, lipase, coags, blood cultures | Sepsis, organ failure, pancreatitis |
| Stool studies: culture, PCR GI panel, CDI toxin | Infectious colitis, C. diff |
| ECG + troponin | AF (AMI source), ACS |
| Type & Screen | AAA, surgical preparation |
Top 15 Differential Diagnosis for a 20-year-old male, with typical or atypical symptoms of fever,productive cough,body aches,morbidly obese,hispanic,hypoxic,blood tinged sputum,severe respiratory distress
| Feature | Detail |
|---|---|
| Why #1 | Obesity (BMI ≥40) is a CDC-designated independent risk factor for severe/fatal influenza — comparable to pregnancy in risk stratification |
| Mechanism | Viral pneumonitis → cytokine storm → diffuse alveolar damage → ARDS |
| Presentation | Abrupt onset: fever, myalgia (body aches), productive cough, hemoptysis, rapidly progressive hypoxia, respiratory failure within 24–72 hrs |
| Blood-tinged sputum | Direct viral hemorrhagic pneumonitis; secondary bacterial superinfection |
| Hispanic risk | During H1N1 2009 pandemic, Hispanic/Latino patients had disproportionately higher ICU admission and mortality rates, strongly linked to higher obesity prevalence |
| Key test | Nasopharyngeal swab (rapid influenza / PCR), CXR (bilateral infiltrates), ABG |
| Complications | Secondary bacterial pneumonia (S. aureus, S. pneumoniae), ARDS, myocarditis |
"ARDS is characterized by noncardiogenic pulmonary edema, heterogeneous infiltrates, decreased lung compliance, and severe hypoxemia... involving injury and increased epithelial–endothelial permeability of the alveoli." — Miller's Anesthesia
| Feature | Detail |
|---|---|
| Organisms | S. pneumoniae (#1), Legionella, Mycoplasma, S. aureus (including MRSA), H. influenzae |
| Presentation | Fever, rigors, productive purulent or rust-colored sputum, pleuritic chest pain, hypoxia |
| Obesity impact | Impaired diaphragmatic excursion, reduced FRC, aspiration risk → faster progression to respiratory failure |
| Blood-tinged sputum | Classic for pneumococcal (rust-colored) or Legionella (blood-streaked) pneumonia |
| Key test | CXR (lobar consolidation), sputum Gram stain/culture, pneumococcal/Legionella urinary antigen, CBC (leukocytosis), procalcitonin |
| Feature | Detail |
|---|---|
| Organisms | Community-acquired MRSA (PVL-positive), Klebsiella pneumoniae (classic in young obese/diabetic males), anaerobes (aspiration) |
| Presentation | High fever, toxic appearance, purulent/bloody sputum, rapid cavitation on imaging |
| PVL-MRSA hallmark | Necrotizing hemorrhagic pneumonia in previously healthy young adults; often follows influenza-like illness; fulminant course with hemoptysis and shock |
| Klebsiella hallmark | "Currant jelly" (red-brown) sputum; upper lobe; associated with diabetes (may be undiagnosed here) |
| Key test | CT chest (cavitation, necrosis, air-fluid levels), blood/sputum cultures, MRSA nasal swab |
| Feature | Detail |
|---|---|
| Why high priority | Morbid obesity is the strongest independent risk factor for severe COVID-19 (3–4× increased risk of ICU admission/death) |
| Presentation | Fever, cough, myalgia (body aches), progressive hypoxia (often "silent hypoxia" initially), respiratory distress; hemoptysis from pulmonary microthrombi |
| Hispanic risk | Disproportionate COVID-19 severity and mortality in Hispanic/Latino populations documented across multiple studies |
| Key test | SARS-CoV-2 PCR (nasopharyngeal), CXR/CT chest (bilateral ground-glass opacities, peripheral distribution), D-dimer, ferritin |
| Feature | Detail |
|---|---|
| Berlin Definition | Acute onset ≤7 days; bilateral opacities (not explained by effusion/collapse); PaO₂/FiO₂ <300 (mild), <200 (moderate), <100 (severe) |
| Causes in this patient | Severe pneumonia (viral/bacterial), aspiration, sepsis, inhalation injury |
| Obesity + ARDS | Morbid obesity reduces chest wall compliance, worsens ventilation-perfusion mismatch, makes prone positioning challenging but beneficial |
| Key test | ABG (PaO₂/FiO₂ ratio), CXR/CT (bilateral diffuse infiltrates), exclude cardiac pulmonary edema (BNP, echo) |
"Hypoxia may be a result of pneumonia, pulmonary contusion, severe pulmonary edema, or acute respiratory distress syndrome (ARDS), among other causes." — Sabiston Textbook of Surgery
| Feature | Detail |
|---|---|
| Epidemiology | Hispanic/Latino individuals in the US have TB incidence ~8× higher than non-Hispanic whites; foreign-born Hispanics carry highest burden |
| Presentation | Productive cough, hemoptysis, fever (often night sweats), weight loss, body aches; can present acutely in immunocompromised or with progressive primary TB |
| Morbid obesity + DM | Type 2 DM (often undiagnosed in young obese Hispanics) is the strongest non-HIV TB risk factor; 3× increased risk of active TB |
| Key test | Sputum AFB smear × 3 + culture, TB PCR (GeneXpert), TST/IGRA, CXR (upper lobe infiltrate, cavitation, hilar adenopathy) |
| Isolation | Airborne precautions mandatory until ruled out |
| Feature | Detail |
|---|---|
| Mechanism | GERD (extremely common in morbid obesity) → microaspiration → bacterial colonization → polymicrobial pneumonia; obstructive sleep apnea worsens nocturnal aspiration |
| Presentation | Fever, productive cough with foul-smelling sputum, hemoptysis, hypoxia; typically RLL or RML distribution |
| Organisms | Anaerobes, gram-negatives, S. aureus |
| Key test | CXR (dependent lobe infiltrate), sputum culture, CT chest |
| Feature | Detail |
|---|---|
| Geographic | Endemic to San Joaquin Valley, Arizona, Texas border, northern Mexico — high Hispanic exposure |
| Severe risk factors | Hispanic/Filipino ethnicity has dramatically increased risk of dissemination; male sex; immunosuppression; diabetes |
| Presentation | Fever, productive cough, hemoptysis, chest pain, body aches, severe hypoxia; may look identical to severe pneumonia |
| Key test | Coccidioides serology (IgM/IgG), sputum culture/stain, urine antigen, CXR (nodules, infiltrates, cavities) |
| Pitfall | Often missed because clinicians forget geographic history; standard antibiotics have no effect |
| Feature | Detail |
|---|---|
| Why in a 20-year-old | Undiagnosed HIV is common in young Hispanic males (higher prevalence in this demographic); also: undiagnosed DM2, steroid use |
| Presentation | Insidious or subacute: progressive dyspnea, nonproductive cough, fever, hypoxia worse with exertion; can present acutely |
| Blood-tinged sputum | Less typical but occurs with diffuse alveolar damage; morbid obesity + PCP → rapid respiratory failure |
| Key test | HIV test (rapid), CD4 count, LDH (markedly elevated in PCP), BAL with silver stain/DFA/PCR, CT chest (bilateral ground-glass "bat-wing" pattern) |
| Feature | Detail |
|---|---|
| Epidemiology | Highest incidence in young Native American and Hispanic males in the American Southwest; rodent exposure |
| Presentation | Prodrome: fever, myalgia, headache (mimics influenza) → rapid-onset pulmonary edema, hemoptysis, severe hypoxia, shock within 4–5 days |
| Why so severe | Capillary leak syndrome → bilateral pulmonary edema despite no cardiac cause |
| Key test | Hantavirus serology (IgM/IgG), CBC (thrombocytopenia, hemoconcentration, atypical lymphocytes — "immunoblasts"), CXR (bilateral interstitial edema) |
| Pitfall | Prodrome is identical to flu; progresses explosively — mortality 30–40% |
| Feature | Detail |
|---|---|
| Mechanism | Morbid obesity → reduced FRC + reduced chest wall compliance + OSA → chronic CO₂ retention → acute decompensation triggered by infection |
| Presentation | Hypoxia + hypercapnia (Type 2 respiratory failure), somnolence, respiratory distress superimposed on fever/infection |
| Key distinction | ABG showing elevated pCO₂ + elevated bicarb (chronic compensation) differentiates from pure infectious ARDS |
| Key test | ABG (pCO₂, bicarb), CXR, pulmonary function tests when stable |
"Patients with obesity (BMI >40 kg/m²) are at risk for cardiovascular and respiratory complications... susceptible to critical respiratory events including hypoventilation, hypoxia, airway obstruction, and acute respiratory failure." — Miller's Anesthesia
| Feature | Detail |
|---|---|
| Mechanism | Venous stasis (obesity, immobility) → DVT → PE → pulmonary infarction → hemoptysis + hypoxia |
| Presentation | Pleuritic chest pain, dyspnea, hemoptysis, tachycardia, hypoxia; fever can occur with infarction |
| Mimicry | Can look like pneumonia on CXR (Hampton's hump); body aches from right heart strain and constitutional response |
| Key test | CTPA (CT pulmonary angiogram), D-dimer, LE duplex ultrasound, troponin/BNP |
"Tachycardia, tachypnea, hypoxia, may have hemoptysis." — Rosen's Emergency Medicine (on PE)
| Feature | Detail |
|---|---|
| Presentation | High fever, dry then productive cough, hemoptysis, myalgias (body aches prominent), diarrhea, confusion, severe hypoxia |
| Risk amplified by obesity | Smoking (often comorbid), immunosuppression from metabolic syndrome |
| Distinguishing features | Hyponatremia, elevated LFTs, elevated CK, relative bradycardia, failure to respond to beta-lactam monotherapy |
| Key test | Legionella urinary antigen (serogroup 1, ~80% sensitive), sputum culture on BCYE agar |
| Feature | Detail |
|---|---|
| Measles pneumonia | Vaccination gaps in Hispanic communities; measles giant cell pneumonia with high fever, cough, hypoxia, Koplik spots, maculopapular rash |
| Adenovirus | Severe hemorrhagic pneumonia in young adults; blood-tinged sputum, high fever, bilateral infiltrates; can be fatal |
| RSV in adults | Increasingly recognized as cause of severe pneumonia in obese/immunocompromised young adults |
| Key test | Respiratory viral panel (PCR), measles titer/IgM, adenovirus PCR |
| Feature | Detail |
|---|---|
| Context | Hispanic males have the highest age-adjusted prevalence of T2DM in the US; morbid obesity dramatically accelerates onset; many are undiagnosed at age 20 |
| Impact | Uncontrolled hyperglycemia → neutrophil dysfunction, impaired innate immunity → unusually severe or atypical presentation of infections: Klebsiella pneumonia, mucormycosis (pulmonary), invasive fungal infections, TB |
| Pulmonary mucormycosis | Rare but devastating; fever, hemoptysis, rapid tissue invasion; associated with uncontrolled DM; can mimic severe pneumonia |
| Key test | Fasting glucose, HbA1c (obtain in every young obese Hispanic with severe infection) |
| # | Diagnosis | Fever | Productive Cough | Hemoptysis | Hypoxia | Body Aches | Obesity Link | Priority |
|---|---|---|---|---|---|---|---|---|
| 1 | Influenza + ARDS | ✅ | ✅ | ✅ | ✅✅ | ✅✅ | ✅✅ Critical | 🔴 |
| 2 | Severe CAP (S. pneumoniae, Legionella) | ✅ | ✅ | ✅ | ✅✅ | ✅ | ✅ | 🔴 |
| 3 | Necrotizing Pneumonia (MRSA/Klebsiella) | ✅✅ | ✅✅ | ✅✅ | ✅✅ | ✅ | ✅ DM risk | 🔴 |
| 4 | COVID-19 Pneumonia / ARDS | ✅ | ✅ | ✅ | ✅✅ | ✅✅ | ✅✅ Critical | 🔴 |
| 5 | ARDS (final pathway) | ✅ | ✅ | ✅ | ✅✅ | ± | ✅ Worsens | 🔴 |
| 6 | Pulmonary TB | ✅ | ✅ | ✅✅ | ✅ | ✅ | ± (DM risk) | 🟠 |
| 7 | Aspiration Pneumonia | ✅ | ✅ | ✅ | ✅ | ± | ✅✅ GERD/OSA | 🟠 |
| 8 | Coccidioidomycosis | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ Hispanic risk | 🟠 |
| 9 | PCP (HIV-related) | ✅ | ✅ | ✅ | ✅✅ | ± | ± | 🟠 |
| 10 | Hantavirus Pulmonary Syndrome | ✅ | ✅ | ✅✅ | ✅✅ | ✅✅ | — Hispanic risk | 🟠 |
| 11 | OHS + Acute-on-Chronic RF | ± | ± | — | ✅✅ | — | ✅✅ Direct | 🟡 |
| 12 | Pulmonary Embolism + Infarction | ± | ± | ✅ | ✅✅ | ± | ✅✅ VTE risk | 🟡 |
| 13 | Legionnaires' Disease | ✅✅ | ✅ | ✅ | ✅✅ | ✅✅ | ✅ | 🟡 |
| 14 | Viral Hemorrhagic Pneumonitis (Measles/Adeno) | ✅✅ | ✅ | ✅✅ | ✅✅ | ✅ | — | 🟡 |
| 15 | Undiagnosed DM2 + Opportunistic Infection | ✅ | ✅ | ✅ | ✅ | ✅ | ✅✅ Direct | 🟡 |
| Study | Targets |
|---|---|
| ABG | Severity of hypoxia (PaO₂/FiO₂), hypercapnia (OHS), acid-base status |
| CXR + CT Chest | Lobar vs. bilateral infiltrates, cavitation (TB/MRSA/Klebsiella), ground-glass (viral/PCP/ARDS), effusion |
| Nasopharyngeal PCR panel | Influenza A/B, SARS-CoV-2, RSV, adenovirus, hantavirus PCR |
| Sputum Gram stain/culture + AFB smear × 3 | CAP organisms, TB — airborne isolation pending |
| Blood cultures × 2 | Bacteremia, septic pneumonia |
| CBC, CMP, lactate, procalcitonin, LDH | Severity, sepsis, PCP (LDH markedly elevated), metabolic status |
| HbA1c + fasting glucose | Undiagnosed DM2 — critical in this demographic |
| HIV rapid test + CD4 | PCP, TB, opportunistic infections |
| Legionella + pneumococcal urinary antigen | CAP workup |
| Coccidioides serology | If Southwest US/Mexico exposure history |
| CTPA | If PE is suspected (Wells score, D-dimer) |
| Hantavirus serology + CBC | Thrombocytopenia + atypical lymphocytes + rodent exposure |
Top 15 Differential Diagnosis for a 1-year-old male, with typical or atypical symptoms of swelling of malnourished,skin appears wrinkled,tented,weight loss,cries when feeding,hypoxic,hypercalcemia,low normal phosphate,low alkaline phosphatase,irregular metaphyses,severe metaphyseal flaring,osteopenia,bilateral hydronephrosis,distended abdomen,choking spell,loss of appetite
⚠️ The single most diagnostically critical lab finding is LOW alkaline phosphatase (ALP) in the context of metaphyseal bone disease. In almost all metabolic bone diseases (rickets, renal osteodystrophy), ALP is elevated. A low ALP with metaphyseal disease is pathognomonic for hypophosphatasia or indicates severe protein-energy malnutrition suppressing bone turnover. This must anchor the differential.
| Feature | Detail |
|---|---|
| Mechanism | Loss-of-function mutations in ALPL gene → deficiency of tissue-nonspecific alkaline phosphatase (TNSALP) → failure to hydrolyze inorganic pyrophosphate → impaired bone mineralization despite normal calcium/phosphate delivery |
| Hallmark lab | Low or absent serum alkaline phosphatase — the defining biochemical feature; universally present |
| Hypercalcemia | Calcium cannot be incorporated into bone → hypercalcemia + hypercalciuria → nephrocalcinosis → bilateral hydronephrosis |
| Low-normal phosphate | Phosphate accumulates abnormally; PLP (pyridoxal-5'-phosphate) markedly elevated in urine/blood |
| Skeletal findings | Severe metaphyseal irregularity, metaphyseal flaring (widened/cupped growth plates), osteopenia, pathologic fractures, rachitic-appearing bones WITHOUT elevated ALP |
| Respiratory | Hypomineralized ribs → chest wall weakness → hypoxia, respiratory failure, choking spells, recurrent pneumonia — leading cause of death |
| GI/feeding | Hypercalcemia → poor appetite, vomiting, crying with feeding, constipation, hypotonia |
| Hydronephrosis | Hypercalciuria → nephrocalcinosis → obstructive uropathy/bilateral hydronephrosis |
| Wasting/skin | Severe systemic failure → malnutrition, wasted appearance, tented/wrinkled skin |
| Severity | Infantile HPP: presents 6 months–1 year; perinatal lethal form is earlier; infantile form has ~50% mortality untreated |
| Key tests | Serum ALP (low/absent), urine/plasma PLP (elevated), phosphoethanolamine in urine, X-rays (metaphyseal changes), ALPL gene sequencing |
| Treatment | Asfotase alfa (enzyme replacement) — FDA approved; dramatically improves survival |
Clinical Pearl: Every feature in this presentation — metaphyseal flaring with LOW ALP, hypercalcemia, bilateral hydronephrosis, hypoxia, wasting, feeding intolerance, choking — fits infantile HPP with remarkable precision. This is the working diagnosis until proven otherwise.
| Feature | Detail |
|---|---|
| Marasmus | Severe caloric deprivation → loss of subcutaneous fat and muscle → wasted, wrinkled skin, tented skin (severe dehydration), prominent bones |
| Kwashiorkor overlap | Protein deficiency → hypoalbuminemia → edema (paradoxical "swelling" despite wasting), distended abdomen (ascites, ileus), hair changes |
| Low ALP | Severe malnutrition suppresses ALP synthesis — this is a well-recognized cause of acquired low ALP in infants |
| Hypercalcemia | Bone resorption exceeds bone formation during starvation → net calcium release → hypercalcemia |
| Skeletal changes | Osteopenia, subperiosteal resorption, metaphyseal irregularity from generalized bone turnover dysfunction |
| Hydronephrosis | Hypercalciuria from bone resorption → nephrocalcinosis, UTI-related obstruction |
| Hypoxia | Respiratory muscle weakness, aspiration (choking), diaphragmatic dysfunction |
| Feeding | Anorexia, abdominal pain, gastric atony — all cause crying with feeding |
| Key tests | Serum albumin (low), prealbumin, transferrin, CBC (anemia), zinc/copper levels, renal ultrasound |
| Feature | Detail |
|---|---|
| Mechanism | Excess vitamin D → excessive calcium absorption + bone resorption → hypercalcemia, hypercalciuria |
| Bone findings | Dense metaphyseal bands (dense "lead lines") OR osteopenia and metaphyseal irregularity from hypercalcemic bone suppression |
| ALP | Can be low-normal or low due to hypercalcemia suppressing bone turnover |
| Hydronephrosis | Hypercalciuria → nephrocalcinosis → bilateral hydronephrosis |
| Symptoms | Anorexia (loss of appetite), vomiting, crying, irritability, constipation, failure to thrive, hypotonia |
| Hypoxia | Hypercalcemia → hypotonia → aspiration, respiratory muscle weakness |
| Key tests | 25-OH-vitamin D level (markedly elevated), serum calcium, urine calcium/creatinine ratio, PTH (suppressed), renal ultrasound |
| History clue | Excess supplementation by well-meaning caregiver; certain fortified foods; granulomatous disease |
| Feature | Detail |
|---|---|
| Mechanism | Microdeletion 7q11.23 (includes ELN gene) → hypersensitivity to vitamin D → hypercalcemia, elfin facies, cardiovascular anomalies |
| Hypercalcemia | Due to abnormal vitamin D metabolism; resolves by age 2–4 in most but can be severe in infancy |
| Bone findings | Osteopenia, metaphyseal irregularity; ALP can be low-normal in hypercalcemic phase |
| Other features | Supravalvular aortic stenosis → hypoxia, poor feeding, failure to thrive, irritability during feeding |
| Renal | Renal artery stenosis, nephrocalcinosis → hydronephrosis; structural renal anomalies common |
| GI/feeding | Severe feeding difficulties, colic, vomiting, constipation — hallmarks in infancy |
| Choking | Hypotonia + feeding difficulties → aspiration → choking spells |
| Key tests | FISH or chromosomal microarray (del 7q11.23), serum calcium, echocardiogram, renal ultrasound, PTH, 25-OH-D |
| Feature | Detail |
|---|---|
| Mechanism | Inactivating mutations in CaSR gene (calcium-sensing receptor) → unregulated PTH secretion → severe hypercalcemia |
| Bone findings | Profound osteopenia, metaphyseal irregularity, subperiosteal resorption, pathologic fractures — "brown tumors" in severe cases |
| Metaphyseal flaring | From PTH-driven excessive osteoclastic activity at growth plates |
| ALP | Typically elevated; but in severe destructive disease with low bone formation rate, can be low-normal |
| Phosphate | Low (PTH promotes urinary phosphate wasting) — low-normal fits |
| Hypercalcemia | Severe, life-threatening in neonatal form |
| Hydronephrosis | Nephrocalcinosis from severe hypercalciuria |
| Symptoms | Hypotonia, feeding refusal, crying, respiratory distress, lethargy |
| Key tests | PTH (markedly elevated), ionized calcium, phosphate, 24-hr urine calcium, CaSR gene sequencing, parathyroid ultrasound |
| Feature | Detail |
|---|---|
| Mechanism | Loss-of-function mutations in CYP24A1 (24-hydroxylase) → inability to degrade active vitamin D → persistent hypercalcemia even with normal vitamin D intake |
| Lab | Hypercalcemia, suppressed PTH, elevated 1,25-OH-D, normal or low ALP (suppressed by hypercalcemia), low-normal phosphate |
| Renal | Hypercalciuria → nephrocalcinosis → bilateral hydronephrosis, renal failure |
| Symptoms | Feeding refusal, vomiting, failure to thrive, weight loss, polyuria, hypotonia |
| Key tests | 1,25-dihydroxyvitamin D (elevated), CYP24A1/SLC34A1 gene panel, urine calcium, renal ultrasound |
| Feature | Detail |
|---|---|
| Menkes disease | X-linked (ATP7A mutation) → severe copper deficiency → abnormal collagen/elastin cross-linking → multisystem disease |
| Bone findings | Metaphyseal irregularity, flaring, "spurs" (Menkes spurs), osteoporosis — radiographically dramatic |
| Key distinction | Wormian bones on skull X-ray, "hair like steel wool" (pili torti), subdural hygroma, tortuous vessels |
| ALP | Low-normal (copper-dependent enzyme) |
| Other features | Hypotonia, feeding difficulty, failure to thrive, seizures, hypothermia |
| Wasting | Severe neurodevelopmental failure → malnourished appearance |
| Hypoxia | Hypotonia + aspiration → choking spells, respiratory failure |
| Hydronephrosis | Bladder diverticula and urinary tract anomalies well-documented in Menkes |
| Key tests | Serum copper (very low), ceruloplasmin (very low), ATP7A gene sequencing, hair microscopy |
| Feature | Detail |
|---|---|
| Mechanism | Vitamin C deficiency → impaired collagen synthesis → defective osteoid formation → metaphyseal disruption |
| Bone findings | "Trümmerfeld zone" (zone of destruction at metaphysis), "Pelkan spurs," periosteal hemorrhage, metaphyseal irregularity, osteopenia |
| Presentation | Irritability (EXTREME — infant screams when touched/moved due to bone pain), tender limbs, refusal to move, poor feeding, pallor |
| Crying with feeding | Perioral/gum hemorrhage, tenderness, anorexia |
| ALP | Low-normal (poor bone formation) |
| Calcium | Can be mildly elevated from bone resorption |
| Wasting | Associated with dietary deficiency, feeding difficulties |
| Key tests | Serum vitamin C (low), X-rays (metaphyseal changes, periosteal elevation), dietary history |
| Feature | Detail |
|---|---|
| Mechanism | Congenital obstructive uropathy → bilateral hydronephrosis → CKD → impaired 1-alpha-hydroxylase → low 1,25-D → BUT can cause hypercalciuria + nephrocalcinosis in distal RTA |
| Distal RTA (Type 1) | Systemic acidosis → bone buffering → bone dissolution → hypercalciuria → nephrocalcinosis → bilateral hydronephrosis |
| Bone | Osteomalacia, metaphyseal irregularity, osteopenia |
| ALP | Usually elevated in renal osteodystrophy, but can be low-normal with severe malnutrition co-existing |
| Presentation | Failure to thrive, poor feeding, vomiting, hypotonia, wasting |
| Key tests | BMP (bicarbonate low in RTA), urinalysis (alkaline urine despite acidemia in dRTA), urine anion gap, renal ultrasound, PTH, 1,25-D |
| Feature | Detail |
|---|---|
| Mechanism | Congenital urethral obstruction → bilateral hydronephrosis + VUR → renal dysplasia → CKD → metabolic bone disease, failure to thrive |
| Why in this list | Male sex, bilateral hydronephrosis, distended abdomen (bladder + ascites), failure to thrive, poor feeding, wasting — all fit |
| Metabolic consequences | CKD → renal osteodystrophy (metaphyseal changes, osteopenia); electrolyte/mineral dysregulation |
| Key tests | Renal/bladder ultrasound (keyhole bladder sign), VCUG (voiding cystourethrogram), creatinine, BMP |
| Feature | Detail |
|---|---|
| Respiratory | Recurrent pneumonia, chronic hypoxia, choking/aspiration — classic in first year |
| GI | Malabsorption → severe malnutrition, wasting, distended abdomen, ileus |
| Bone | Fat-soluble vitamin malabsorption (vitamins D, K) → rickets-like bone disease, osteopenia |
| Feeding | Loss of appetite, crying with feeding, failure to thrive |
| Key tests | Sweat chloride test, newborn screening (IRT/DNA), fecal elastase, fat-soluble vitamin levels |
| Feature | Detail |
|---|---|
| Classic injuries | Classic metaphyseal lesions (CML) — "bucket handle" or "corner" fractures at metaphyses; highly specific for non-accidental trauma |
| Why on this list | Metaphyseal irregularity + bone changes + wasting + hypoxia (from inflicted head trauma or suffocation) + failure to thrive |
| Critical distinction from HPP | NAT: ALP usually NORMAL or elevated (healing fractures); HPP: ALP LOW. This distinction is medico-legally critical |
| Additional findings | Posterior rib fractures, subdural hematoma, retinal hemorrhages, skin bruising in non-mobile infant |
| Wasting | Nutritional neglect co-existing |
| Key tests | Full skeletal survey, ophthalmology (retinal hemorrhages), CT head, social work evaluation |
⚠️ This diagnosis must always be considered and documented. Conversely, HPP with metaphyseal changes has been mistakenly reported as NAT — causing wrongful child removal. The ALP level is the critical differentiator.
| Feature | Detail |
|---|---|
| Mechanism | Cyanotic CHD or severe left-to-right shunt → chronic hypoxia → poor feeding, wasting, sweating with feeds (crying), failure to thrive |
| Bone effects | Chronic hypoxia + malnutrition → secondary osteopenia, metaphyseal irregularity |
| Hypercalcemia | Williams syndrome (supravalvular AS) — the most direct link to both hypercalcemia AND CHD |
| Hydronephrosis | Renal anomalies commonly co-occur with CHD syndromes |
| Key tests | Echocardiogram, CXR, pulse oximetry, ECG, BNP |
| Feature | Detail |
|---|---|
| Examples | Methylmalonic acidemia (MMA), propionic acidemia, mitochondrial complex deficiencies, Gaucher disease |
| Why on this list | Multisystem failure: metabolic bone disease, metabolic acidosis, failure to thrive, wasting, hypotonia, hepatomegaly (distended abdomen), renal involvement |
| Bone findings | Osteopenia, metaphyseal changes from metabolic acidosis-driven bone buffering |
| ALP | Can be low in mitochondrial disease (enzyme synthesis impaired) |
| Presentation | Episodic decompensation with feeding, vomiting, lethargy, hypoxia, failure to thrive |
| Key tests | Plasma amino acids, urine organic acids, plasma acylcarnitine profile, lactate/pyruvate, ammonia, mitochondrial DNA panel |
| # | Diagnosis | Hyper-Ca | Low ALP | Metaphyseal Disease | Bilateral Hydronephrosis | Hypoxia | Wasting/Feeding | Priority |
|---|---|---|---|---|---|---|---|---|
| 1 | Hypophosphatasia (HPP) | ✅ | ✅✅ Pathognomonic | ✅✅ Severe | ✅ | ✅✅ | ✅✅ | 🔴 |
| 2 | Severe PEM (Marasmus/Kwashiorkor) | ✅ | ✅ Suppressed | ✅ | ✅ | ✅ | ✅✅ | 🔴 |
| 3 | HPP + Malnutrition (Combined) | ✅✅ | ✅✅ | ✅✅ | ✅✅ | ✅✅ | ✅✅ | 🔴 |
| 4 | Hypervitaminosis D | ✅✅ | ✅ Low-normal | ✅ Dense bands | ✅ | ✅ | ✅✅ | 🟠 |
| 5 | Williams Syndrome | ✅✅ | ✅ | ✅ | ✅ | ✅✅ CHD | ✅✅ | 🟠 |
| 6 | Neonatal Hyperparathyroidism | ✅✅ | ± Elevated/low | ✅✅ | ✅ | ✅ | ✅✅ | 🟠 |
| 7 | IIH (CYP24A1/SLC34A1) | ✅✅ | ✅ | ✅ | ✅ | ✅ | ✅✅ | 🟠 |
| 8 | Menkes Disease | ± | ✅ Low-normal | ✅✅ Spurs | ✅ | ✅✅ | ✅✅ | 🟠 |
| 9 | Scurvy | ± | ✅ | ✅✅ Trümmerfeld | — | — | ✅ | 🟠 |
| 10 | CKD / Distal RTA | ± | ± | ✅ | ✅✅ | ✅ | ✅✅ | 🟡 |
| 11 | Posterior Urethral Valves | — | — | ✅ Secondary | ✅✅ Primary | ✅ | ✅✅ | 🟡 |
| 12 | Cystic Fibrosis | — | ± | ✅ D-deficiency | — | ✅✅ | ✅✅ | 🟡 |
| 13 | Non-Accidental Trauma | — | Normal/↑ | ✅✅ CML | — | ✅ (head) | ✅ Neglect | 🟡 |
| 14 | Congenital Heart Disease | ✅ Williams | ± | ✅ Secondary | ✅ Syndromes | ✅✅ | ✅✅ | 🟡 |
| 15 | Inborn Error of Metabolism | — | ✅ | ✅ Acidosis | ✅ | ✅ | ✅✅ | 🟡 |
| Study | What It Targets |
|---|---|
| Serum ALP (repeat, confirm low) | HPP diagnosis anchor — if truly low with bone disease, HPP is #1 |
| Serum/plasma pyridoxal-5'-phosphate (PLP) | Elevated in HPP — highly specific |
| Urine phosphoethanolamine | Elevated in HPP |
| ALPL gene sequencing | Confirms HPP |
| Ionized calcium, phosphate, PTH, 25-OH-D, 1,25-OH-D | HPP, hyperparathyroidism, hypervitaminosis D, IIH, Williams |
| 24-hr urine calcium/creatinine ratio | Hypercalciuria → nephrocalcinosis source |
| Renal/bladder ultrasound | Bilateral hydronephrosis — grade + cause |
| VCUG | If PUV/VUR suspected |
| Serum copper + ceruloplasmin | Menkes disease |
| Chromosomal microarray (SNP array) | Williams syndrome (del 7q11.23) |
| Echocardiogram | Williams (supravalvular AS), CHD |
| Full skeletal survey X-rays | Characterize metaphyseal changes; distinguish HPP from NAT |
| Plasma amino acids, urine organic acids, acylcarnitine | IOM screen |
| HbA1c, albumin, prealbumin, zinc, vitamin C | Nutritional status, scurvy |
| Sweat chloride | Cystic fibrosis |
| Ophthalmology (retinal exam) | NAT (retinal hemorrhages) |
| Chest X-ray + ABG | Hypoxia characterization, rib mineralization (HPP) |
Top 15 Differential Diagnosis for a 45-year-old male, with typical or atypical symptoms of relapsing fever,pancytopenia
Key diagnostic question: Is the pancytopenia causing the fever (via neutropenic infections) — or is the same underlying disease causing both independently?
| Feature | Detail |
|---|---|
| Mechanism | Malignant blasts replace normal marrow → pancytopenia; fever from marrow-derived cytokines (IL-1, IL-6, TNF) + neutropenic infections |
| Relapsing fever | Cytokine-driven tumor fever that waxes/wanes; superimposed episodic infections from neutropenia |
| AML peak | Bimodal — young adults and >45; the 45-year-old male is in the prime AML risk window |
| Presentation | Fatigue, pallor, bleeding (thrombocytopenia), recurrent infections, bone pain, hepatosplenomegaly |
| "Aleukemic leukemia" | WBC can be low (not high) — pancytopenia without circulating blasts — easily mistaken for aplastic anemia |
| Key tests | Peripheral smear (blasts?), bone marrow biopsy + aspirate (>20% blasts = AML), flow cytometry, cytogenetics/FISH |
"It is important to distinguish aplastic anemia from other causes of pancytopenia, such as 'aleukemic' leukemia and myelodysplastic neoplasm, which may have identical clinical manifestations." — Robbins, Cotran & Kumar
| Feature | Detail |
|---|---|
| Mechanism | T-cell–mediated destruction of hematopoietic stem cells → hypocellular marrow → pancytopenia |
| Relapsing fever | Recurrent bacterial/fungal infections from profound neutropenia; fever episodes track with neutrophil nadir |
| Peak age | Bimodal: 15–25 and >60; but the 45-year-old presentation is well-recognized |
| Triggers | Drugs (NSAIDs, antibiotics, antiepileptics), viral infections (EBV, hepatitis, parvovirus B19), idiopathic |
| Severity | Severe: ANC <500; Very severe: ANC <200 — life-threatening |
| Key tests | Bone marrow biopsy (hypocellular, fatty marrow, no blasts), CBC with differential, flow cytometry (exclude PNH), cytogenetics |
"The diagnosis of aplastic anemia is usually straightforward, based on the combination of pancytopenia with a fatty bone marrow." — Harrison's Principles of Internal Medicine (22e)
| Feature | Detail |
|---|---|
| Mechanism | Clonal hematopoietic stem cell disorder → ineffective hematopoiesis → peripheral pancytopenia despite normocellular/hypercellular marrow (paradox) |
| Relapsing fever | Recurrent infections from dysfunctional neutrophils; constitutional cytokine-driven fever |
| Age | Median diagnosis ~70, but MDS in 45-year-olds is increasingly recognized (therapy-related MDS from prior chemo/radiation is important here) |
| Presentation | Fatigue, macrocytic anemia, bleeding, recurrent infections; may transform to AML (30%) |
| Key tests | Peripheral smear (hypersegmented neutrophils, pseudo-Pelger-Huët anomaly, dysplastic cells), bone marrow biopsy + aspirate, cytogenetics (del 5q, monosomy 7), FISH, NGS panel |
"An occasional patient has hypocellular marrow and a clonal cytogenetic abnormality, which establishes the diagnosis [of MDS vs. aplastic anemia]." — Goldman-Cecil Medicine
| Feature | Detail |
|---|---|
| Mechanism | Uncontrolled macrophage and T-cell activation → massive cytokine storm → phagocytosis of all blood cell lines by activated macrophages in marrow, spleen, liver |
| Relapsing/persistent fever | Hallmark: prolonged high fever (>38.5°C) that does not respond to antibiotics — one of the 5 diagnostic HScore criteria |
| Pancytopenia | All three lines destroyed; often severe |
| Triggers in adult males | EBV, CMV, HIV, lymphoma (especially NK/T-cell), SLE, adult-onset Still's disease |
| HScore criteria | Fever, splenomegaly, cytopenias, hyperferritinemia (often >10,000 ng/mL), elevated triglycerides, fibrinogen low, hemophagocytosis on marrow bx, elevated sCD25, low/absent NK function |
| Key tests | Ferritin (markedly elevated — >500 is suspicious; >10,000 is highly specific), triglycerides, fibrinogen, bone marrow biopsy (hemophagocytosis), sCD25, NK cell function |
| Feature | Detail |
|---|---|
| Relapsing pattern | P. vivax/ovale: hypnozoites in liver → true relapse weeks to months after initial infection; tertian fever (every 48 hrs) |
| Pancytopenia mechanism | Hemolysis (RBC destruction) → anemia; hypersplenism from massive splenomegaly → thrombocytopenia + leukopenia |
| Classic presentation | Paroxysms: cold stage → hot stage (fever 39–40°C) → sweating stage, recurring every 48–72 hrs; fatigue, headache, myalgias, splenomegaly |
| P. falciparum | Non-relapsing but causes severe pancytopenia + can be fatal |
| Travel/exposure | Sub-Saharan Africa, South/Southeast Asia, Central America — ask travel history meticulously |
| Key tests | Thick and thin peripheral blood smear (×3, 12-hr intervals), rapid malaria antigen test (RDT), malaria PCR (most sensitive), CBC (anemia, thrombocytopenia), LFTs, LDH |
| Feature | Detail |
|---|---|
| HIV mechanisms | Direct marrow suppression; immune dysregulation → autoimmune cytopenias; antiretroviral drug toxicity (zidovudine → severe anemia/pancytopenia) |
| Relapsing fever | Recurrent OIs: PCP, MAC (Mycobacterium avium complex — classic relapsing fever + pancytopenia in AIDS), CMV, histoplasmosis, disseminated TB |
| MAC | Causes fever that recurs cyclically, night sweats, weight loss, and profound pancytopenia via marrow infiltration |
| Presentation | Wasting, lymphadenopathy, oral thrush, chronic diarrhea, hepatosplenomegaly |
| Key tests | HIV Ag/Ab 4th generation test, CD4 count, viral load, bone marrow biopsy (if MAC/histoplasma suspected), mycobacterial blood cultures |
| Feature | Detail |
|---|---|
| Mechanism | Leishmania donovani invades macrophages in marrow, spleen, liver → hypersplenism + direct marrow infiltration → pancytopenia |
| Relapsing fever | Classically irregular/remittent fever with two daily peaks; persists weeks to months; profound systemic illness |
| Classic triad | Prolonged fever + massive splenomegaly + pancytopenia |
| Other features | Weight loss, darkening of skin (kala-azar = "black fever" in Hindi), hepatomegaly, weakness |
| Geography | Indian subcontinent, East Africa, Mediterranean, Brazil, Middle East |
| Key tests | Leishmania serology (rK39 rapid test — high sensitivity in India/Africa), bone marrow/spleen aspirate (amastigotes), Leishmania PCR, CBC (all lines low) |
| Feature | Detail |
|---|---|
| Mechanism | Hematogenous spread → miliary foci in bone marrow → granulomatous replacement of marrow → pancytopenia; fever from cytokines |
| Relapsing fever | Classically a prolonged, daily (quotidian) or irregular fever; can appear to relapse with antibiotic courses that partially suppress co-infections |
| Presentation | Weight loss, night sweats, cough, hepatosplenomegaly, lymphadenopathy, miliary pattern on CXR |
| Marrow involvement | Granulomas on bone marrow biopsy — diagnostic; AFB stain + culture |
| Key tests | CXR (miliary pattern), sputum AFB, IGRA/TST, bone marrow biopsy (AFB stain + culture + histology), blood culture (Bactec MGIT), CT chest/abdomen |
| Feature | Detail |
|---|---|
| Relapsing pattern | Undulant fever — the textbook term; fever rises and falls in waves over weeks; may spontaneously remit then recur |
| Pancytopenia | Brucella infects macrophages in marrow → granulomatous infiltration; hypersplenism from splenomegaly → all three lines suppressed |
| Presentation | Arthralgia, myalgia, malaise, hepatosplenomegaly, night sweats, weight loss |
| Exposure | Raw dairy products (unpasteurized milk/cheese), livestock contact (farmers, veterinarians, abattoir workers), Middle East/Mediterranean/Latin America |
| Key tests | Brucella serology (standard tube agglutination — STA ≥1:160 diagnostic), Brucella blood/bone marrow culture (slow — takes 4 weeks), Brucella PCR |
| Feature | Detail |
|---|---|
| Relapsing pattern | Classic febrile paroxysms lasting 3–7 days, resolving with "crisis," recurring 5–9 days later (can relapse 3–5 times) |
| Mechanism | Antigenic variation of outer surface proteins (Vmp) allows spirochetes to evade antibody → cyclic spirochetemia → cyclical fever |
| Pancytopenia | Thrombocytopenia (platelet consumption), anemia (hemolysis), leukopenia (sequestration) |
| Vectors | Louse-borne (B. recurrentis): epidemic in refugee settings, Ethiopia; Tick-borne (B. hermsii/turicatae): western US, Africa |
| Key tests | Peripheral blood smear during febrile episode (spirochetes visible in ~70%), Borrelia PCR, serology |
| Feature | Detail |
|---|---|
| EBV mechanism | Primary EBV → hemophagocytic syndrome; chronic active EBV (CAEBV) → recurrent fever, pancytopenia, NK/T-cell lymphoma risk |
| CMV | Severe CMV viremia → marrow suppression; relapsing in immunocompromised (HIV, post-transplant) |
| Pancytopenia | Direct marrow suppression + hypersplenism + hemophagocytosis |
| Relapsing | Viral reactivation cycles → periodic febrile episodes; CAEBV presents with years of recurrent illness |
| Key tests | EBV VCA IgM/IgG, EBV PCR (viral load), CMV PCR, heterophile antibodies (monospot), peripheral smear (atypical lymphocytes), bone marrow biopsy |
| Feature | Detail |
|---|---|
| Pancytopenia mechanisms | Autoimmune hemolytic anemia (warm IgG AIHA), immune thrombocytopenia, autoimmune neutropenia, drug-induced marrow suppression |
| Relapsing fever | Lupus flares → fever (often low-grade, but high-grade in severe flares); mimics infection |
| Male SLE | Less common but often more severe disease; higher rates of nephritis and serositis |
| Other features | Malar rash, photosensitivity, arthritis, serositis, nephritis, oral ulcers, neuropsychiatric SLE |
| Key tests | ANA (>1:160), anti-dsDNA, anti-Smith, complement (C3/C4 low in active disease), urinalysis (proteinuria, casts), CBC, Coombs test |
| Feature | Detail |
|---|---|
| B symptoms | Classic: fever >38°C, drenching night sweats, weight loss >10% in 6 months — these "relapse" in cycles in Hodgkin's (Pel-Ebstein fever) |
| Pel-Ebstein fever | Specific to Hodgkin's lymphoma — alternating weeks of fever and afebrile periods — the quintessential cyclical fever in hematology |
| Pancytopenia | Marrow infiltration displaces normal hematopoiesis; hypersplenism from splenomegaly |
| Age 45 | NHL (especially DLBCL) peaks in this decade; Hodgkin's has a secondary peak at 45–55 |
| Key tests | CT-PET scan, bone marrow biopsy, lymph node biopsy (core or excisional), LDH, uric acid, beta-2 microglobulin |
"Due to low blood counts, fatigue, lassitude, easy bleeding, and fever are common. Beyond symptoms related to marrow replacement and the attendant pancytopenia..." — Robbins & Kumar Basic Pathology
| Feature | Detail |
|---|---|
| Mechanism | Histoplasma infects macrophages in reticuloendothelial system → marrow granulomas → pancytopenia; hepatosplenomegaly |
| Relapsing fever | Chronic or subacute: low-grade persistent fever with episodic spikes; constitutional symptoms |
| Geography | Ohio/Mississippi River valleys, Latin America, Southeast Asia; can reactivate years later |
| Immunocompromised | AIDS, organ transplant, anti-TNF therapy (adalimumab, infliximab) — rapidly progressive disseminated form |
| Other features | Oral ulcers, skin lesions, adrenal insufficiency (adrenal involvement) |
| Key tests | Urine Histoplasma antigen (most sensitive in disseminated disease), serum antigen, blood culture (Bactec lysis centrifugation), bone marrow biopsy, serologies |
| Feature | Detail |
|---|---|
| Mechanism | Somatic PIGA mutation → GPI-anchor deficiency → complement-mediated destruction of RBCs, WBCs, platelets → hemolytic anemia + thrombocytopenia + leukopenia |
| Relapsing fever | Episodic hemolytic crises → fever from hemolysis; aplastic anemia co-exists in 30% of PNH → recurrent infectious fevers from neutropenia |
| Classic triad | Hemolytic anemia + thrombosis + cytopenias |
| Thrombosis | Unusual sites: hepatic vein (Budd-Chiari), portal vein, cerebral sinus — highly suspicious feature |
| Urine | Hemoglobinuria (dark/tea-colored urine, especially morning) |
| Key tests | Flow cytometry (CD55/CD59 deficiency on RBCs and granulocytes) — the diagnostic standard, LDH (markedly elevated during crisis), Coombs test (negative — distinguishes from AIHA), bone marrow biopsy |
| # | Diagnosis | Relapsing Fever Type | Pancytopenia Mechanism | Priority |
|---|---|---|---|---|
| 1 | Acute Leukemia (AML/ALL) | Tumor cytokines + neutropenic infection | Marrow replacement by blasts | 🔴 |
| 2 | Aplastic Anemia | Neutropenic bacterial/fungal infections | T-cell marrow destruction | 🔴 |
| 3 | Myelodysplastic Syndrome (MDS) | Cytokines + dysfunctional neutrophil infections | Ineffective hematopoiesis | 🔴 |
| 4 | HLH | Persistent/relapsing from cytokine storm | Hemophagocytosis of all lines | 🔴 |
| 5 | Malaria (P. vivax/ovale) | Tertian/quartan — true relapse from hypnozoites | Hemolysis + hypersplenism | 🔴 |
| 6 | HIV/AIDS + OIs (MAC) | Cyclic OI-driven (MAC, histoplasma) | Marrow infiltration + drug toxicity | 🔴 |
| 7 | Visceral Leishmaniasis (Kala-azar) | Irregular, prolonged undulant | Marrow infiltration + hypersplenism | 🟠 |
| 8 | Miliary/Disseminated TB | Quotidian or irregular | Granulomatous marrow infiltration | 🟠 |
| 9 | Brucellosis | Undulant (classic weeks-long waves) | Granulomatous marrow + hypersplenism | 🟠 |
| 10 | Relapsing Fever Borreliosis | Paroxysmal 3–7 days on/off (classic) | Hemolysis + thrombocytopenia + sequestration | 🟠 |
| 11 | EBV/CMV — Severe/Chronic Active | Periodic reactivation fever | Marrow suppression + hemophagocytosis | 🟠 |
| 12 | SLE (Adult Male) | Autoimmune flare fever | AIHA + ITP + autoimmune neutropenia | 🟡 |
| 13 | Lymphoma (NHL/Hodgkin's) | Pel-Ebstein (Hodgkin's) or B-symptom fever | Marrow infiltration + hypersplenism | 🟡 |
| 14 | Histoplasmosis (Disseminated) | Chronic subacute + episodic spikes | Granulomatous marrow infiltration | 🟡 |
| 15 | Paroxysmal Nocturnal Hemoglobinuria (PNH) | Hemolytic crisis fever + neutropenic | Complement-mediated destruction + aplasia | 🟡 |
| Test | Purpose |
|---|---|
| CBC with differential + peripheral smear | Blasts? Atypical lymphs? Malaria parasites? Dysplasia? Spherocytes? |
| Reticulocyte count | Hypoproliferative (marrow failure) vs. hemolytic (high retic) |
| LDH, uric acid, haptoglobin | Hemolysis (LDH↑, haptoglobin↓), marrow turnover, tumor lysis |
| Ferritin (if >500 → HLH protocol) | HLH screening |
| Coombs (direct antiglobulin test) | AIHA vs. PNH (both anemic but DAT differs) |
| Comprehensive metabolic panel | Hepatic/renal involvement |
| Coagulation (PT/INR, fibrinogen) | DIC (in AML, HLH) |
| Test | Purpose |
|---|---|
| Thick/thin blood smear × 3 (12-hr intervals) | Malaria |
| Malaria RDT + PCR | Malaria (if smear negative) |
| Brucella agglutination + culture | Brucellosis |
| Borrelia smear + PCR | Relapsing fever borreliosis |
| HIV Ag/Ab (4th gen) | HIV; if positive → CD4, viral load, mycobacterial cultures |
| EBV/CMV PCR | Viral marrow suppression |
| Leishmania rK39 + PCR | Visceral leishmaniasis |
| Urine Histoplasma antigen | Disseminated fungal |
| TB IGRA + sputum AFB + blood culture (Bactec) | Miliary TB |
| Test | Purpose |
|---|---|
| Bone marrow biopsy + aspirate | Blasts (AML/ALL), hypocellularity (aplastic anemia), dysplasia (MDS), granulomas (TB/Brucella/Histoplasma), amastigotes (Leishmania), hemophagocytosis (HLH), lymphoma infiltration |
| Flow cytometry (bone marrow) | Immunophenotyping for leukemia/lymphoma; CD55/CD59 for PNH |
| Cytogenetics + FISH + NGS | Clonal abnormalities (MDS, AML) |
| AFB stain + culture (marrow) | TB, MAC |
| Test | Purpose |
|---|---|
| CT-PET scan | Lymphoma staging, spleen size |
| ANA, anti-dsDNA, complement | SLE |
| Triglycerides, fibrinogen, sCD25, NK function | Complete HLH criteria |
| PNH flow cytometry (peripheral blood) | CD55/CD59 on RBCs and granulocytes |
| LFTs, hepatitis B/C | Drug-induced aplasia trigger; viral hepatitis-associated aplasia |
Top 15 Differential Diagnosis for a 2-year-old male, with typical or atypical symptoms of constipation,severe abdominal bloating,abdominal discomfort
| Feature | Detail |
|---|---|
| Mechanism | Absence of ganglion cells (Meissner's and Auerbach's plexuses) in a segment of colon → failure of internal anal sphincter relaxation → functional obstruction → proximal colonic dilatation/megacolon |
| Why at age 2 | Short-segment HD and ultra-short-segment HD may escape neonatal diagnosis; long-segment HD detected late in developing countries; presents when stool burden becomes unmanageable |
| Classic features | Never had a normal bowel pattern since birth; constipation from day 1 (no meconium passage within 48 hrs in neonatal form); severe abdominal distension, ribbon-like stools, explosive decompression when rectal exam performed |
| "Empty rectum" | Digital rectal exam: empty ampulla despite distended abdomen — hallmark that distinguishes HD from functional constipation (where rectum is loaded with stool) |
| Dangerous complication | Hirschsprung-associated enterocolitis (HAEC) — toxic megacolon, fever, septic shock, perforation — life-threatening |
| Key tests | Contrast enema (transition zone from narrow aganglionic segment to dilated proximal colon), rectal suction biopsy (absence of ganglia + acetylcholinesterase staining) — gold standard, anorectal manometry |
"In the toddler or older child, HD must be differentiated from functional constipation (stool withholding, fecal retention). With fecal retention, history indicates that the child did pass meconium in the newborn nursery, and clinical problems did not arise until the toddler period." — Sleisenger & Fordtran's GI and Liver Disease
| Feature | Detail |
|---|---|
| Mechanism | Voluntary stool withholding (pain avoidance, toilet training conflict) → stool accumulates → hard/large stool → more pain → vicious cycle → fecal impaction → colonic distension |
| Age 2 | Peak age for toilet training struggles; transition from diapers → potty → high withholding behavior |
| Distinguishing features from HD | History of normal meconium passage at birth; normal bowel habit in infancy; onset correlating with toilet training; rectum loaded with stool on exam |
| Bloating | Massive fecal loading + gas from fermentation of retained stool → severe distension |
| Abdominal discomfort | Cramping from peristalsis against obstructed bowel; referred discomfort |
| Encopresis | Liquid stool leaks around impaction → parents confuse with "diarrhea" — important to ask |
| Key tests | Clinical diagnosis; abdominal X-ray (fecal loading pattern), rectal exam (stool-filled rectum) |
| Feature | Detail |
|---|---|
| Mechanism | Congenital narrowing or malposition of anus → relative outflow obstruction → stool backup, bloating |
| Presentation | Lifelong difficulty with defecation; ribbon/small-caliber stools; abdominal distension; no history of normal early stools |
| Key test | Careful anorectal inspection (position, caliber of anus), digital examination, anoscopy, contrast enema |
| Feature | Detail |
|---|---|
| Mechanism | Immune-mediated villous atrophy in response to gliadin → malabsorption of fat, carbohydrates, and micronutrients → altered gut motility; gas from fermentation of unabsorbed carbohydrates |
| Why at age 2 | Gluten introduced at 6–12 months; symptoms typically appear 6–18 months after introduction → age 1.5–2.5 is peak presentation |
| Constipation in celiac | Counterintuitive but well-documented — 10–15% of celiac children present with constipation rather than diarrhea; altered intestinal motility and bloating are hallmarks |
| Classic picture | Pot-belly/abdominal distension, wasted buttocks, irritability, failure to thrive, pallor (iron deficiency anemia) |
| Key tests | Tissue transglutaminase IgA (tTG-IgA) + total IgA (to exclude IgA deficiency), endomysial antibody; small bowel biopsy (villous atrophy, crypt hyperplasia) — on a gluten-containing diet |
| Feature | Detail |
|---|---|
| Mechanism | Non-IgE mediated immune response to cow's milk proteins → proctocolitis/colitis → altered colonic motility, reduced peristalsis → constipation and bloating |
| Prevalence | ~17% of constipated children have CMPA as a contributing factor |
| Presentation | Constipation + abdominal bloating + colic/discomfort; may have history of eczema, wheezing (atopic march) |
| Diagnostic test | 4-week elimination diet (no cow's milk/dairy) → resolution of constipation → rechallenge → recurrence = diagnostic |
| Key tests | Skin prick test, specific IgE (RAST) — often negative in non-IgE form; elimination/rechallenge is more informative |
| Feature | Detail |
|---|---|
| Mechanism | Hypothyroidism → decreased GI motility (bradyperistalsis) → constipation, bloating, abdominal distension |
| Acquired hypothyroidism in toddlers | Autoimmune thyroiditis (Hashimoto's) — most common acquired cause; rare at 2 but possible; iodine deficiency in certain regions |
| Congenital missed | Newborn screen false negatives in very preterm infants or delayed TSH rise |
| Other features | Puffy facies, dry skin, coarse hair, bradycardia, lethargy, cold intolerance, umbilical hernia, macroglossia, short stature, delayed development |
| Key tests | TSH (elevated), free T4 (low), anti-TPO antibody (if autoimmune), thyroid ultrasound |
| Feature | Detail |
|---|---|
| Mechanism | Thick, inspissated mucus in intestinal lumen → viscous stool → obstruction in terminal ileum and cecum; exocrine pancreatic insufficiency worsens malabsorption and stool consistency |
| DIOS | Accumulation of fecal material in terminal ileum/cecum → RLQ mass, severe bloating, complete or incomplete obstruction |
| Also | Exocrine pancreatic insufficiency → fatty malabsorption → malodorous stools, bloating, failure to thrive |
| Presentation at 2 | May have had milder symptoms since birth; recurrent constipation with abdominal bloating; failure to thrive; recurrent respiratory infections |
| Key tests | Sweat chloride (>60 mmol/L diagnostic), CFTR mutation analysis, fecal elastase (low = exocrine insufficiency), abdominal X-ray |
| Feature | Detail |
|---|---|
| Mechanism | Lead inhibits smooth muscle contractility + autonomic innervation → constipation, intestinal cramping; "lead colic" |
| Pica | Age 2 is peak age for pica (non-food ingestion) — lead paint chips, soil, ceramics; renovated older homes |
| Presentation | Constipation, colicky abdominal pain, irritability, developmental regression, pallor (anemia), behavioral changes |
| Severe poisoning | Encephalopathy (rare but critical), peripheral neuropathy, "lead lines" on gingiva (Burton lines) and metaphyseal bone bands |
| Bloating | From constipation/ileus + abdominal cramping |
| Key tests | Blood lead level (BLL ≥5 µg/dL = elevated; ≥45 µg/dL = chelation threshold), CBC (microcytic anemia, basophilic stippling), abdominal X-ray (radio-opaque particles in GI tract if recent ingestion) |
| Feature | Detail |
|---|---|
| Mechanism | Tethered spinal cord, sacral agenesis, spinal lipoma, or occult spina bifida → neurogenic dysfunction of internal anal sphincter and colon → severe constipation |
| Presentation | Constipation that does not respond to standard therapy; abnormal gait, urinary incontinence, leg weakness, sacral dimple/hair tuft/skin lesion on lower back |
| Key tests | MRI lumbosacral spine (tethered cord, lipoma, syrinx), spinal X-ray, urodynamic studies, anorectal manometry |
| Feature | Detail |
|---|---|
| Mechanism | Neuropathic or myopathic dysfunction of intestinal smooth muscle/enteric nervous system → absent or disorganized peristalsis → functional obstruction → massive distension |
| Presentation | Severe, recurrent abdominal distension, constipation, vomiting, failure to thrive from early life |
| Distinguishing | Imaging shows massively dilated bowel without mechanical transition point; normal contrast enema excludes HD |
| Key tests | Abdominal X-ray/CT (dilated bowel without obstruction), contrast enema (no transition zone), antroduodenal manometry, full-thickness intestinal biopsy |
| Feature | Detail |
|---|---|
| Hypercalcemia | Hypercalcemia → decreased smooth muscle excitability → constipation, bloating, abdominal pain; causes: hyperparathyroidism, Williams syndrome, hypervitaminosis D, malignancy |
| Hypokalemia | Potassium is essential for intestinal smooth muscle action potential → hypokalemia → ileus, severe constipation, abdominal distension |
| Key tests | BMP (Ca²⁺, K⁺, Mg²⁺, HCO₃⁻), PTH, 25-OH-D, urine Ca/Cr |
| Feature | Detail |
|---|---|
| Age | Both Wilms tumor (nephroblastoma) and neuroblastoma peak at 1–4 years |
| Mechanism | Tumor compresses sigmoid colon, rectum, or mesentery → relative obstruction → constipation; abdominal distension from mass itself |
| Presentation | Firm, non-tender abdominal mass (often found incidentally or on constipation workup); failure to thrive; hypertension (Wilms) |
| Bloating | Combination of mass effect + secondary constipation |
| Key tests | Abdominal ultrasound (mass location, vascularity), CT abdomen/pelvis with IV contrast, urine catecholamines (VMA/HVA for neuroblastoma), urinalysis |
| Feature | Detail |
|---|---|
| Giardia | Most common protozoan in toddlers (daycare exposure); bloating, flatulence, altered stool pattern (diarrhea alternating with constipation), abdominal discomfort, foul-smelling stool |
| Ascaris (roundworm) | Heavy worm burden → intestinal obstruction → constipation + severe distension; classic in developing countries |
| Enterobius | Pinworm-related anal pruritus and discomfort → stool withholding → functional constipation |
| Key tests | Stool O&P × 3, Giardia antigen stool ELISA, Scotch tape test (pinworm), abdominal X-ray (Ascaris visible as "whittled wood" filling defects) |
| Feature | Detail |
|---|---|
| Mechanism | Clostridium botulinum spores germinate in GI tract → produce botulinum toxin → blocks ACh release at neuromuscular junctions → constipation (often the first symptom), generalized hypotonia, weakness |
| Presentation | Constipation → hypotonia, poor feeding, weak cry, ptosis, bulbar palsy; age 2 is late but possible with honey exposure or environmental spores |
| Key tests | Stool botulinum toxin + culture (gold standard), clinical (constipation + hypotonia), EMG (incremental response at high frequency) |
| Feature | Detail |
|---|---|
| Mechanism | Altered gut-brain axis, dysbiosis, food selectivity (restricted diet low in fiber), decreased physical activity, behavioral withholding |
| At age 2 | ASD diagnosis often first suspected/made at 18–24 months; GI symptoms may be the presenting complaint to general pediatrics |
| Presentation | Severe chronic constipation, abdominal bloating/discomfort, pain expressed as self-injurious behavior or irritability (child cannot communicate pain verbally) |
| Dietary | Extreme food selectivity (often high-carb, low-fiber diet) directly worsens constipation |
| Key tests | Developmental screening (M-CHAT-R at 18–24 months), dietary history, abdominal X-ray, clinical constipation management trial |
| # | Diagnosis | Constipation | Bloating | Discomfort | Key Distinguisher | Priority |
|---|---|---|---|---|---|---|
| 1 | Hirschsprung Disease | ✅✅ Lifelong | ✅✅ Severe | ✅ | Empty rectum on DRE; transition zone on contrast enema | 🔴 |
| 2 | Functional Constipation / Fecal Impaction | ✅✅ | ✅✅ | ✅ | Normal meconium hx; rectum loaded; toilet training onset | 🔴 |
| 3 | Anorectal Malformation / Anal Stenosis | ✅✅ | ✅✅ | ✅ | Structural abnormality on inspection; narrow caliber stools | 🔴 |
| 4 | Celiac Disease | ✅ (10–15%) | ✅✅ | ✅ | Pot-belly, wasting; tTG-IgA positive; biopsy | 🟠 |
| 5 | Cow's Milk Protein Allergy | ✅ | ✅ | ✅ | Response to dairy elimination; atopic history | 🟠 |
| 6 | Hypothyroidism | ✅✅ | ✅ | ✅ | TSH elevated; puffy facies, lethargy, dry skin | 🟠 |
| 7 | Cystic Fibrosis / DIOS | ✅ | ✅✅ | ✅ | Sweat chloride; FTT; respiratory symptoms | 🟠 |
| 8 | Lead Poisoning | ✅ | ✅ | ✅✅ Colic | BLL elevated; pica behavior; developmental delay | 🟠 |
| 9 | Tethered Cord / Spinal Dysraphism | ✅✅ | ✅ | ✅ | Refractory constipation; sacral skin lesion; MRI | 🟠 |
| 10 | Intestinal Pseudo-Obstruction (CIPO) | ✅✅ | ✅✅ | ✅ | Massive distension; no transition zone; early life onset | 🟡 |
| 11 | Hypercalcemia / Hypokalemia | ✅ | ✅ | ✅ | BMP abnormal; systemic symptoms | 🟡 |
| 12 | Wilms / Neuroblastoma / Lymphoma | ✅ | ✅✅ | ✅ | Palpable abdominal mass; ultrasound | 🟡 |
| 13 | Intestinal Parasites (Giardia/Ascaris) | ✅ | ✅✅ | ✅ | Daycare/travel exposure; stool O&P | 🟡 |
| 14 | Infant Botulism | ✅ First symptom | ✅ | ✅ | Hypotonia; honey exposure; stool toxin assay | 🟡 |
| 15 | ASD-Related GI Dysfunction | ✅✅ | ✅ | ✅ (expressed as irritability) | Developmental concerns; food selectivity; M-CHAT-R | 🟡 |
| Action | Purpose |
|---|---|
| Detailed history | Meconium passage at birth? (HD vs. functional); Dietary history; Milk/dairy intake; Developmental milestones; Pica behavior; Housing (lead paint); Travel |
| Digital rectal examination | Empty rectum (HD) vs. stool-filled rectum (functional) — the single most informative physical finding |
| Abdominal exam | Mass? Distension pattern (central vs. peripheral)? Tenderness localization? |
| Inspect lower spine and sacrum | Sacral dimple, hairy patch, asymmetry (tethered cord) |
| Inspect anus | Position, caliber, fissures |
| Test | Purpose |
|---|---|
| Abdominal X-ray (supine + upright) | Fecal loading, bowel gas pattern, obstruction, calcifications, worm burden |
| TSH + free T4 | Hypothyroidism |
| BMP (Ca²⁺, K⁺, Mg²⁺, Na⁺, HCO₃⁻) | Electrolyte causes |
| Blood lead level | Lead poisoning — mandatory in all toddlers with constipation in older housing |
| Stool O&P × 3 + Giardia antigen | Parasitosis |
| Sweat chloride | Cystic fibrosis |
| Test | Purpose |
|---|---|
| Contrast enema (water-soluble) | Transition zone (HD), stricture, mass effect |
| Rectal suction biopsy | HD (gold standard — done under sedation) |
| Abdominal ultrasound | Mass, organomegaly, renal abnormality (Wilms) |
| MRI lumbosacral spine | Tethered cord |
| tTG-IgA + total IgA | Celiac disease |
| Specific IgE / elimination trial | CMPA |
| Stool botulinum toxin | If hypotonic infant |
| Developmental evaluation (M-CHAT-R) | ASD |
Top 15 Differential Diagnosis for a 2-year-old male, with typical or atypical symptoms of Sore throat,fever,ulcers on tonsillar arches
| Feature | Detail |
|---|---|
| Pathogen | Coxsackievirus A (A2, A4, A5, A6, A8, A10 most common), Enterovirus 71, echovirus |
| Mechanism | Enteroviral cytopathic effect on pharyngeal epithelium → small vesicles → ulcers |
| Ulcer location | Classically on anterior tonsillar pillars (faucial arches), soft palate, uvula, posterior pharynx — NOT on the gums, lips, or buccal mucosa |
| Appearance | Small (1–2 mm), grayish-white ulcers with erythematous halos on tonsillar arches and soft palate; typically 5–10 lesions |
| Fever | Abrupt onset, high (38.5–40°C), preceding or simultaneous with ulcers |
| Sore throat | Painful swallowing → refusal to eat/drink → risk of dehydration |
| Age | Peak: 6 months – 5 years; age 2 is classic |
| Season | Summer and fall in temperate climates |
| No hand/foot lesions | Distinguishes from Hand-Foot-Mouth disease (though overlap exists) |
| Course | Self-limited, 3–7 days; no specific antiviral treatment |
| Key tests | Clinical diagnosis; throat/stool viral PCR or culture if diagnosis uncertain; rapid strep test (negative) |
"A majority of cases [of pharyngitis] are viral and caused by common cold viruses." — Rosen's Emergency Medicine
| Feature | Detail |
|---|---|
| Pathogen | Coxsackievirus A16 (classic), Enterovirus A71 (EV-A71 — more severe), CVA6 (more extensive rash) |
| Oral ulcers | Ulcers/vesicles on tonsillar arches, soft palate, buccal mucosa, tongue, gums — more widespread than herpangina |
| Distinguishing feature | Vesicular/maculopapular lesions on palms, soles, and interdigital spaces — absent in herpangina |
| Fever | High, abrupt onset |
| Sore throat | Painful → refusal to drink → dehydration risk |
| EV-A71 concern | Can cause neurological complications (brainstem encephalitis, flaccid paralysis, pulmonary edema) — must monitor closely for neurological signs |
| Age | Peak: 6 months – 5 years; highly contagious in daycare |
| Key tests | Clinical diagnosis; EV-A71 PCR if severe neurological signs; vesicle swab for viral PCR |
| Feature | Detail |
|---|---|
| Pathogen | HSV-1 (primary infection — first exposure) |
| Ulcer location | Extensive ulcers on gums, buccal mucosa, tongue, lips + tonsillar area involvement — more diffuse than herpangina; tonsillar arch ulcers can occur |
| Appearance | Clusters of shallow, painful ulcers; gingiva markedly swollen, red, bleeding; halitosis |
| Fever | High (39–40°C), prolonged (5–7 days) |
| Hallmark | Gingivitis (swollen, bleeding gums) — NOT seen in herpangina or HFMD |
| Drooling | Profuse drooling from pain and inability to swallow; refusal to eat/drink |
| Duration | 10–14 days — longer than herpangina |
| Complication | Severe dehydration (common hospitalization reason at this age); rarely viral encephalitis |
| Treatment | Acyclovir (oral/IV) if started within 72 hours — shortens course; supportive hydration |
| Key tests | Clinical (most reliable); HSV PCR from swab of lesion, Tzanck smear (multinucleated giant cells) |
| Feature | Detail |
|---|---|
| Pathogen | Streptococcus pyogenes (Group A Strep) |
| Classic features | Sudden onset fever, sore throat, tonsillar exudate (white/yellow patches on tonsils), palatal petechiae, anterior cervical lymphadenopathy; NO cough |
| Ulcers | GAS typically causes exudate, not discrete ulcers — but ulceration of tonsillar tissue can occur in severe cases |
| Age 2 | GAS pharyngitis is less common under age 3 but not rare; Centor/McIsaac criteria less reliable in this age group |
| Importance | Untreated GAS → acute rheumatic fever (ARF) → carditis, mitral valve disease; post-streptococcal glomerulonephritis |
| Treatment | Amoxicillin × 10 days (penicillin-allergic → azithromycin) — mandatory for GAS |
| Key tests | Rapid antigen detection test (RADT) — high specificity; throat culture (gold standard, 24–48 hrs); ASO titer (retrospective) |
"The most common bacterial causes of acute tonsillitis are group A β-hemolytic streptococcus species (GABHS) and S. pneumoniae. If GABHS is confirmed, then antibiotic therapy is warranted in the pediatric population to decrease the risk (3%) of developing [rheumatic fever]." — Schwartz's Principles of Surgery
| Feature | Detail |
|---|---|
| Mechanism | Dysregulated innate immune response → predictable cyclic inflammatory episodes; exact etiology unknown |
| Cycle | Predictable febrile episodes every 3–6 weeks, lasting 3–6 days, then complete resolution |
| Triad | Aphthous ulcers (can be on tonsillar arches/oral mucosa) + pharyngitis + cervical adenitis |
| Fever | High (39–40°C), abrupt onset, precisely cyclical |
| Age | Onset typically 2–5 years; this patient fits perfectly |
| Key clue | Between episodes the child is completely healthy and grows normally — differentiates from immunodeficiency |
| Diagnosis | Clinical (Marshall criteria); all infectious workup between episodes is normal |
| Treatment | Single dose of prednisone at onset of episode aborts the fever within hours (also diagnostic); cimetidine for prophylaxis; tonsillectomy is curative in many cases |
"Syndrome of periodic fever, pharyngitis, and aphthous stomatitis... Periodic fevers with aphthous stomatitis, pharyngitis, and adenitis (PFAPA)." — Cummings Otolaryngology Head and Neck Surgery
| Feature | Detail |
|---|---|
| Pathogen | Epstein-Barr virus (EBV) |
| Oral findings | Massive tonsillar enlargement + gray-white exudate/pseudomembrane ± petechiae at junction of hard and soft palate ± ulceration of tonsillar area |
| Pharyngitis | Severe sore throat — often the dominant complaint |
| Fever | Prolonged (1–3 weeks), high grade |
| Other features | Posterior cervical lymphadenopathy (prominent), hepatosplenomegaly, fatigue, periorbital edema |
| Age 2 | EBV in toddlers often milder than in adolescents; less classic "kissing disease" picture |
| Risk | Airway compromise from massive tonsillar enlargement — emergency |
| Key tests | Monospot (heterophile antibody) — often negative under age 4 (use EBV-specific antibodies instead); EBV VCA IgM/IgG, CBC (lymphocytosis with atypical lymphocytes), LFTs |
| Feature | Detail |
|---|---|
| Adenovirus | Can produce severe exudative pharyngitis indistinguishable from GAS; may have conjunctivitis (pharyngoconjunctival fever — adenovirus triad: fever + pharyngitis + conjunctivitis) |
| Parainfluenza | Croup + pharyngitis in same child — characteristic barking cough |
| Presentation | Fever, sore throat, variable severity; ulcers/vesicles less typical than enteroviral but can occur |
| Key tests | Respiratory viral panel (PCR); negative rapid strep test; clinical |
| Feature | Detail |
|---|---|
| Pathogen | Fusospirochetal organisms (Fusobacterium nucleatum + Treponema vincentii) — synergistic |
| Presentation | Painful gray/black necrotic ulcers with pseudomembrane on tonsillar area and gingiva; fetid odor (halitosis); fever; bleeding gums |
| Risk factors | Poor oral hygiene, malnutrition, immunodeficiency, stress |
| At age 2 | Uncommon but seen in malnourished or immunocompromised children |
| Treatment | Penicillin + metronidazole; gentle debridement |
| Key tests | Clinical + Gram stain (fusiform bacteria + spirochetes); CBC (leukocytosis) |
| Feature | Detail |
|---|---|
| Presentation | Prolonged fever, pharyngitis, cervical lymphadenopathy, hepatosplenomegaly; oral ulcers in immunocompromised |
| Distinction from EBV | Monospot negative; less severe pharyngitis; more prominent hepatitis |
| Key tests | CMV PCR (blood/urine), CMV IgM/IgG, CBC (atypical lymphocytes), LFTs |
| Feature | Detail |
|---|---|
| Oral findings | Vesicles → ulcers on soft palate, tonsillar area, buccal mucosa — can mimic herpangina |
| Distinguishing | Characteristic skin rash — pruritic vesicles in multiple stages (macule → papule → vesicle → crust) on trunk, face, scalp |
| Fever | Low-grade to high; preceding rash by 1–2 days |
| Vaccination | May occur in partially immunized children (breakthrough varicella — milder course) |
| Key tests | Clinical; VZV PCR from skin/oral lesion if uncertain; IgM |
| Feature | Detail |
|---|---|
| Mechanism | Cyclic neutropenia: ANC nadir every 21 days → oral/tonsillar ulcers, fever, lymphadenopathy during nadir; congenital severe neutropenia (Kostmann syndrome) |
| Oral ulcers | Aphthous-type ulcers on buccal mucosa, gingiva, tonsillar area — appear during neutropenic phases |
| Critical | Can progress to severe bacterial infections (sepsis, pneumonia) during nadir |
| Key clue | Recurrent oral ulcers + recurrent infections + recurrent fever on a 3-week cycle |
| Key tests | Serial CBC × 3 weeks (twice weekly) to document ANC cycling; neutrophil elastase (ELANE) gene mutation |
| Feature | Detail |
|---|---|
| Classic oral findings | Strawberry tongue, cracked/fissured erythematous lips, erythema of oral mucosa — NOT ulcers typically |
| Atypical Kawasaki | Can present with pharyngitis, oral ulceration, and fever before other classic criteria appear |
| Danger | Coronary artery aneurysms develop in untreated cases (25%) → myocardial infarction |
| Other criteria | Fever ≥5 days + ≥2 of: bilateral conjunctivitis, polymorphous rash, cervical lymphadenopathy ≥1.5 cm, extremity changes (edema → desquamation) |
| Key tests | Echocardiogram, CBC (thrombocytosis in 2nd week), ESR/CRP (markedly elevated), ANA/ANCA (negative), IVIG response |
| Feature | Detail |
|---|---|
| Presentation | Sore throat, low-grade fever (surprisingly mild early), gray-white adherent pseudomembrane on tonsils/pharynx extending to uvula and palate; bleeds when removed |
| Ulcers | Membrane can ulcerate tonsillar and palatal tissue underneath |
| Danger | Airway obstruction from membrane extension; myocarditis (diphtheria toxin); polyneuropathy |
| "Bull neck" | Massive cervical lymphadenopathy + submandibular swelling |
| Vaccination status | Ask explicitly — global resurgence in regions with vaccine hesitancy |
| Key tests | Throat culture on Loeffler/tellurite medium; PCR for diphtheria toxin gene (tox); antitoxin treatment must NOT await culture |
| Feature | Detail |
|---|---|
| Mechanism | Leukemic marrow replacement → neutropenia → impaired mucosal immunity → oral/tonsillar ulcers + secondary infections |
| Age | ALL peaks at 2–5 years — this child is in the prime window |
| Presentation | Recurrent fever, oral/tonsillar ulcers, pallor, petechiae/bruising, bone pain, lymphadenopathy, hepatosplenomegaly |
| Why it mimics pharyngitis | Neutropenic ulcers + fever + sore throat can be the presenting complaint before blood work is checked |
| Critical clue | Symptoms not resolving + pallor + easy bruising + any lymphadenopathy → CBC immediately |
| Key tests | CBC with differential (blasts on smear, pancytopenia, or markedly elevated WBC), LDH, uric acid, bone marrow biopsy |
| Feature | Detail |
|---|---|
| Mechanism | Systemic vasculitis → recurrent painful oral ulcers (aphthous), genital ulcers, uveitis, skin lesions |
| Oral ulcers | Recurrent, large, deep, painful ulcers on any oral surface including tonsillar arches and soft palate |
| Fever | With flares; systemic illness |
| Epidemiology | Middle East, Turkey, East Asia ("Silk Road disease") — ask ethnic/geographic background |
| Diagnosis | International Behçet's criteria: recurrent oral ulcers + ≥2 of: genital ulcers, eye lesions, skin lesions, positive pathergy test |
| Key tests | Clinical criteria; ESR/CRP, HLA-B51 (associated), ophthalmology evaluation |
| # | Diagnosis | Fever | Sore Throat | Ulcers on Tonsillar Arches | Key Distinguisher | Priority |
|---|---|---|---|---|---|---|
| 1 | Herpangina (Coxsackievirus A) | ✅ High, abrupt | ✅✅ | ✅✅ Classic location | Ulcers on arches/soft palate; summer/fall; no skin lesions | 🔴 |
| 2 | Hand-Foot-Mouth Disease | ✅ | ✅✅ | ✅ + buccal/tongue | Vesicles on palms/soles/interdigital | 🔴 |
| 3 | Primary HSV Gingivostomatitis | ✅✅ Prolonged | ✅✅ | ✅ (+ gingiva, lips) | Gingivitis + drooling; most diffuse | 🔴 |
| 4 | Group A Strep Pharyngitis | ✅ | ✅✅ | ± (exudate > ulcers) | Tonsillar exudate; no cough; RADT+ | 🟠 |
| 5 | PFAPA Syndrome | ✅✅ Cyclic | ✅✅ | ✅ Aphthous | Predictable 3–6 wk cycle; prednisone response | 🟠 |
| 6 | EBV Mononucleosis | ✅ Prolonged | ✅✅ | ✅ (exudate > ulcers) | Posterior cervical nodes; splenomegaly; monospot neg <4y | 🟠 |
| 7 | Adenovirus / Viral Pharyngitis | ✅ | ✅ | ± | Conjunctivitis (pharyngoconjunctival fever); RADT negative | 🟠 |
| 8 | Vincent's Angina | ✅ | ✅✅ | ✅✅ Necrotic gray | Fetid odor; gingival bleeding; poor hygiene/immune | 🟠 |
| 9 | CMV Pharyngitis | ✅ | ✅ | ± | Monospot neg; hepatitis; EBV serology negative | 🟠 |
| 10 | Varicella (Chickenpox) | ✅ | ✅ | ✅ Soft palate | Pruritic vesicular skin rash in multiple stages | 🟠 |
| 11 | Cyclic/Congenital Neutropenia | ✅ Cyclic | ✅ | ✅✅ Aphthous | Recurrent ulcers q21 days; ANC nadir on CBC | 🟡 |
| 12 | Kawasaki Disease (Atypical) | ✅✅ ≥5 days | ✅ | ± | Strawberry tongue; rash; conjunctivitis; coronary risk | 🟡 |
| 13 | Diphtheria | ✅ Low-grade | ✅✅ | ± (pseudomembrane) | Adherent gray membrane; bleeds; airway; unvaccinated | 🟡 |
| 14 | Acute Leukemia (ALL) | ✅ | ✅ | ✅ Neutropenic | Pallor; bruising; lymphadenopathy; CBC with blasts | 🟡 |
| 15 | Behçet's Disease (Juvenile) | ✅ | ✅ | ✅✅ Large/deep recurrent | Genital ulcers; uveitis; HLA-B51; Silk Road ethnicity | 🟡 |
| Action | Key Finding |
|---|---|
| Inspect ulcer location precisely | Tonsillar arches only (herpangina) vs. gingiva/lips/tongue (HSV) vs. palms/soles (HFMD) vs. genitals (Behçet's) |
| Check for skin lesions | Vesicles on hands/feet (HFMD), chickenpox rash, petechiae/purpura (leukemia) |
| Examine gingiva | Swollen/bleeding gums = HSV; normal gums = herpangina |
| Palpate lymph nodes | Anterior cervical (GAS); posterior cervical (EBV); generalized (leukemia) |
| Smell breath | Fetid = Vincent's angina |
| Check abdomen | Splenomegaly (EBV, leukemia) |
| Check vaccination history | Varicella, diphtheria (DTaP) |
| Test | Purpose |
|---|---|
| Rapid strep test (RADT) ± throat culture | Exclude/confirm GAS — mandatory |
| CBC with differential | Leukemia (blasts), neutropenia (cyclic/congenital), atypical lymphocytes (EBV/CMV) |
| Monospot | EBV — NOTE: often false negative under age 4 |
| EBV VCA IgM/IgG + CMV IgM | If monospot negative but EBV/CMV suspected |
| Respiratory viral PCR panel | Adenovirus, enterovirus, other viruses |
| HSV PCR (lesion swab) | If HSV gingivostomatitis suspected |
| Test | Purpose |
|---|---|
| Serial CBC × 3 weeks | Cyclic neutropenia |
| Echocardiogram | Kawasaki (if fever ≥5 days + other criteria) |
| Throat culture (Loeffler's medium) | Diphtheria if unvaccinated + pseudomembrane |
| Bone marrow biopsy | Leukemia if blasts/pancytopenia on CBC |
| ESR, CRP, HLA-B51 | Behçet's disease |
| CRP + response to prednisone | PFAPA (single prednisone dose aborts PFAPA episode) |
Top 15 Differential Diagnosis for a 45-year-old male, with typical or atypical symptoms of severe epistaxis | history of recurrent nosebleeds | history of frequent migraines | cutaneous | oral mucosal telangiectasia
Recurrent epistaxis + cutaneous telangiectasia + oral mucosal telangiectasia + migraines in a 45-year-old male = Hereditary Hemorrhagic Telangiectasia (HHT) until proven otherwise.
| Feature | Detail |
|---|---|
| Genetics | Autosomal dominant; mutations in ENG (endoglin — HHT1), ACVRL1 (ALK1 — HHT2), SMAD4 (juvenile polyposis-HHT overlap); incomplete penetrance |
| Mechanism | Defective TGF-β/BMP signaling in endothelium → abnormal vessel wall development → arteriovenous malformations (AVMs) and telangiectasias in multiple organs |
| Telangiectasia | Multiple small, punctate, red-purple, slightly elevated lesions on lips, tongue, buccal mucosa, palate, fingertips, face, nasal septum — hallmark of this presentation |
| Epistaxis | Most common presenting symptom (90–95% of patients) — spontaneous, recurrent, often severe; typically begins in childhood/adolescence, worsening by age 45; can cause iron-deficiency anemia |
| Migraines | Mechanistically important: pulmonary AVMs allow paradoxical emboli (right-to-left shunting) → cerebral microemboli → migraine with aura, TIA, stroke; also direct cerebral AVMs cause vascular headaches |
| Pulmonary AVMs (30–50%) | Dyspnea, cyanosis, paradoxical embolism → stroke, brain abscess; hypoxia on exertion; CXR: nodular densities; CT chest: diagnostic |
| Cerebral AVMs (10–20%) | Intracranial hemorrhage, seizures, focal neurological deficits |
| Hepatic involvement (30–70%) | Liver AVMs → high-output cardiac failure, portal hypertension, biliary disease |
| GI telangiectasia | GI bleeding (second most common bleeding manifestation); occult blood loss → anemia |
| Curaçao Diagnostic Criteria | ≥3 of 4 = definite HHT: (1) Epistaxis — spontaneous, recurrent; (2) Telangiectasias — multiple, at characteristic sites; (3) Visceral lesions (pulmonary/hepatic/cerebral AVMs, GI); (4) Family history — first-degree relative with HHT |
| This patient meets 3 criteria | Epistaxis ✅ + Telangiectasias (cutaneous + oral) ✅ + likely family history (autosomal dominant) ✅ → Definite HHT |
"Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Rendu-Weber syndrome, is an autosomal dominant disorder that is manifested by vascular ectasia in various organs, including the skin and mucus membranes." — Fishman's Pulmonary Diseases and Disorders
"Also known as Osler-Weber-Rendu disease, hereditary hemorrhagic telangiectasia (HHT) is characterized by small tufts of dilated capillaries scattered over the mucous membranes and the skin. These slightly elevated lesions develop mostly on the lips, tongue, palate, nasal mucosa..." — Andrews' Diseases of the Skin
"Osler-Weber-Rendu disease (hereditary hemorrhagic telangiectasia): forms spider-like blood vessels or angiomatous-appearing lesions on the oral mucosa, tongue, and nasal mucosa; associated with recurrent epistaxis; gastrointestinal tract may be involved and transfusion may be required." — K.J. Lee's Essential Otolaryngology
"Patients typically have visible telangiectasias on their lips and mucous membranes, as well as telangiectasias in their gastrointestinal tract and other organs..." — Goldman-Cecil Medicine
| Feature | Detail |
|---|---|
| CREST | Calcinosis cutis, Raynaud's phenomenon, Esophageal dysmotility, Sclerodactyly, Telangiectasia |
| Telangiectasia | Multiple mat-like telangiectasias on face (perioral, perinasal), hands, oral mucosa, trunk — can closely resemble HHT |
| Epistaxis | Nasal mucosal telangiectasias → recurrent epistaxis; less severe than HHT typically |
| Distinguishing features | Raynaud's phenomenon (very common, often the first symptom); skin tightening (sclerodactyly); calcinosis in fingertips; esophageal dysmotility (GERD, dysphagia); positive anti-centromere antibody (ACA) |
| No pulmonary AVMs | CREST causes pulmonary hypertension from obliterative vasculopathy, NOT AVMs — key difference from HHT |
| Migraine connection | Raynaud's-like cerebrovascular vasospasm can cause migraine-type headaches |
| Key tests | ANA (speckled), anti-centromere antibody (positive in 70–80% CREST), anti-Scl-70 (diffuse SSc), nailfold capillaroscopy |
"Limited cutaneous PSS (CREST syndrome)... manifestations described by the CREST acronym: calcinosis, Raynaud, esophageal sclerosis, sclerodactylism, and telangiectasia." — Quick Compendium of Clinical Pathology
| Feature | Detail |
|---|---|
| Mechanism | Deficiency/dysfunction of von Willebrand factor (VWF) → impaired platelet adhesion to subendothelium → mucosal bleeding |
| Presentation | Recurrent epistaxis, menorrhagia, easy bruising, gingival bleeding, prolonged bleeding after procedures |
| Telangiectasia | VWD itself does NOT cause telangiectasia — if telangiectasia is present, consider HHT + VWD coexisting (HHT patients can have secondary acquired VWD from shear-stress degradation of VWF through AVMs) |
| Acquired VWD | HHT with large hepatic or pulmonary AVMs can cause acquired VWD (high-shear states degrade VWF multimers) — important interaction |
| Key tests | VWF antigen, VWF activity (Ristocetin cofactor), Factor VIII activity, VWF multimer analysis, bleeding time (prolonged), platelet count (normal) |
"In type 1 VWD, patients have predominantly mucosal bleeding symptoms... Bleeding symptoms are uncommon in infancy and usually manifest later in childhood with excessive bruising and epistaxis." — Harrison's Principles of Internal Medicine (22e)
| Feature | Detail |
|---|---|
| Mechanism | Uncontrolled hypertension → increased intravascular pressure → rupture of nasal vessels, particularly Kiesselbach's plexus |
| Epistaxis type | More commonly posterior epistaxis (internal carotid territory — harder to control); severe, profuse |
| Telangiectasia | Hypertension alone does NOT cause telangiectasia — if both are present, underlying HHT with hypertension as precipitant |
| Migraines | Hypertension can cause headache; hypertensive urgency/emergency → severe headache mimicking migraine |
| Key tests | Serial blood pressure measurements, BMP, urinalysis (hypertensive nephropathy), fundoscopy (AV nicking, flame hemorrhages) |
| Feature | Detail |
|---|---|
| Mechanism | ATM gene mutation → defective DNA repair → neurodegeneration, telangiectasia, immunodeficiency, cancer predisposition |
| Telangiectasia | Conjunctival telangiectasias (classic — first site, age 2–8), then cutaneous and mucosal |
| Neurological | Progressive cerebellar ataxia (presents age 1–2), neuropathy, oculomotor apraxia — may manifest as "migraine-like" headaches or neurological episodes |
| At age 45 | Classic A-T is a childhood disease; but mild/variant forms (A-T complementation group variants) can present in adulthood with telangiectasia + neurological features |
| Key tests | Serum AFP (elevated in 95%), immunoglobulins (IgA/IgG deficient), ATM protein by Western blot, ATM gene sequencing |
| Feature | Detail |
|---|---|
| Cerebral AVMs in HHT | Present in 10–20% of HHT patients; typically diagnosed in 3rd–5th decade |
| Migraine mechanism | Cerebral AVMs → focal cortical spreading depression → migraine with aura; right-to-left pulmonary shunting → platelet microemboli → cortical ischemia triggers → vascular headaches |
| Important distinction | Patients with HHT + migraines should undergo MRI brain with gadolinium to screen for cerebral AVMs before any endovascular procedure |
| Key tests | MRI brain with gadolinium (cerebral AVMs), CT chest with IV contrast (pulmonary AVMs), echocardiography with bubble study (intracardiac/intrapulmonary shunting) |
| Feature | Detail |
|---|---|
| Spider angiomata | Found in liver disease — look similar to telangiectasia; caused by elevated estrogen levels from impaired hepatic metabolism |
| Epistaxis | Coagulopathy (decreased clotting factors, thrombocytopenia from hypersplenism) → prolonged bleeding from nasal vessels |
| Distinguishing | Spider angiomata blanch with pressure and refill from central arteriole (spider); HHT telangiectasia are flat, punctate, non-radial |
| Other features | Jaundice, ascites, hepatomegaly/splenomegaly, palmar erythema, caput medusae, asterixis |
| Key tests | LFTs, albumin, INR/PT, platelet count, hepatitis B/C serology, abdominal ultrasound with Doppler |
| Feature | Detail |
|---|---|
| Thrombocytopenia | ITP (immune thrombocytopenic purpura), hematologic malignancy, aplastic anemia, drug-induced → severe recurrent epistaxis |
| Qualitative disorders | Bernard-Soulier syndrome, Glanzmann thrombasthenia, drug-induced (aspirin, NSAIDs, clopidogrel) — platelet count normal but function impaired |
| Telangiectasia | NOT caused by platelet disorders — if telangiectasias are present, this diagnosis alone is insufficient |
| Key tests | CBC with platelet count, peripheral smear, PT/PTT, platelet aggregation studies, PF4 antibodies (HIT) |
| Feature | Detail |
|---|---|
| Lesions | Unilateral port-wine stain (face, V1 distribution) + leptomeningeal angiomata + glaucoma |
| Neurological | Seizures, migraines, hemiplegia, intellectual disability |
| Telangiectasia | Facial cutaneous vascular lesion (port-wine stain) — differs from HHT punctate telangiectasias |
| Epistaxis | From nasal mucosal involvement of vascular malformation |
| Key tests | MRI brain (leptomeningeal enhancement, cortical atrophy), ophthalmology (glaucoma screening) |
| Feature | Detail |
|---|---|
| Presentation | Compressible blue, rubber, bleb-like venous malformations on skin + GI tract → GI bleeding, intussusception |
| Cutaneous lesions | Blue-purple compressible blebs — different from flat telangiectasias of HHT |
| Epistaxis | From nasal mucosal venous malformations |
| Key tests | Endoscopy (GI lesions), MRI soft tissue, clinical recognition |
| Feature | Detail |
|---|---|
| POEMS | Polyneuropathy, Organomegaly, Endocrinopathy, M-protein, Skin changes |
| Skin | Cutaneous telangiectasias, hemangiomata, skin thickening, hyperpigmentation |
| Epistaxis | Thrombocytosis (paradoxically common) with vascular fragility; thrombosis and bleeding |
| Neurological | Peripheral neuropathy; central nervous system involvement can cause headaches |
| Key tests | Serum/urine protein electrophoresis (M-spike), VEGF level (markedly elevated — diagnostic clue), bone marrow biopsy |
| Feature | Detail |
|---|---|
| Mechanism | Drug-induced impairment of coagulation cascade or platelet function → recurrent epistaxis |
| Telangiectasia | NOT caused by anticoagulants — drug therapy may unmask previously asymptomatic HHT or VWD |
| Key | Always ask medication history in any patient with recurrent epistaxis |
| Key tests | PT/INR (warfarin monitoring), medication review |
| Feature | Detail |
|---|---|
| Mechanism | Cocaine vasoconstriction → ischemic necrosis of nasal mucosa/septum → perforation → recurrent epistaxis |
| Presentation | Recurrent unilateral or bilateral epistaxis; saddle nose deformity (late); nasal septal perforation on exam |
| Telangiectasia | NOT caused by cocaine — if telangiectasia present, this is a complicating cofactor |
| Key tests | Nasal endoscopy (septal perforation, mucosal atrophy), urine drug screen |
| Feature | Detail |
|---|---|
| Mechanism | Increased red cell mass → hyperviscosity → congestion of mucosal vessels → epistaxis; also platelet dysfunction despite thrombocytosis |
| Presentation | Plethoric facies (ruddy complexion), epistaxis, pruritus (especially after hot shower), headaches, splenomegaly, thrombosis |
| Telangiectasia | Dilated engorged vessels on face and mucosa can resemble telangiectasia |
| Migraines | Hyperviscosity → cerebrovascular events → headaches/migraines |
| Key tests | CBC (markedly elevated Hgb, HCT, RBC), JAK2 V617F mutation (>95% PV), serum erythropoietin (low in PV) |
| Feature | Detail |
|---|---|
| Mechanism | Age-related vascular changes, low humidity, nasal mucosal dryness, Kiesselbach's plexus fragility |
| At age 45 | Anterior epistaxis from Kiesselbach's plexus most common; posterior epistaxis more serious |
| Telangiectasia | Sun-damaged skin (fair-skinned males) → actinically induced telangiectasia; rosacea-associated telangiectasia (face, nose) |
| Rosacea | Facial flushing, telangiectasia of nose/cheeks, rhinophyma — can cause nasal mucosal telangiectasia + epistaxis |
| Diagnosis | Only after HHT, CREST, VWD, and other organic causes excluded |
| Key tests | Complete coagulation screen, nasal endoscopy, genetics (HHT panel) |
| # | Diagnosis | Recurrent Epistaxis | Cutaneous/Oral Telangiectasia | Migraines | Key Distinguisher | Priority |
|---|---|---|---|---|---|---|
| 1 | HHT (Osler-Weber-Rendu) | ✅✅ Hallmark | ✅✅ Pathognomonic | ✅ Pulmonary/cerebral AVMs | Curaçao criteria ≥3/4; AD family history | 🔴 |
| 2 | CREST / Limited SSc | ✅ | ✅✅ | ✅ (vasospasm) | Raynaud's; sclerodactyly; anti-centromere Ab | 🟠 |
| 3 | Von Willebrand Disease | ✅✅ | ✗ (alone) | — | Mucosal bleeding; VWF antigen/activity low | 🟠 |
| 4 | Uncontrolled Hypertension | ✅ Posterior | ✗ (alone) | ✅ | Elevated BP; no telangiectasia per se | 🟠 |
| 5 | Ataxia-Telangiectasia | ✅ | ✅ (conjunctival first) | ✅ (neurological) | Ataxia; AFP elevated; ATM mutation | 🟠 |
| 6 | HHT + Cerebral AVM (migraine-dominant) | ✅✅ | ✅✅ | ✅✅ | MRI brain AVM; bubble study positive | 🟠 |
| 7 | Cirrhosis / Liver Disease | ✅ | ✅ (spider angiomata) | — | Jaundice; LFT abnormal; coagulopathy | 🟠 |
| 8 | Platelet Disorders / ITP | ✅✅ | ✗ | — | Thrombocytopenia; no telangiectasia | 🟠 |
| 9 | Sturge-Weber Syndrome | ✅ | ✅ (port-wine stain) | ✅ seizures | Unilateral port-wine stain; leptomeningeal AVM | 🟡 |
| 10 | Blue Rubber Bleb Nevus | ✅ | ✅ (blue blebs) | — | Compressible blue blebs; GI bleeding | 🟡 |
| 11 | POEMS Syndrome | ✅ | ✅ | ✅ neuropathy | VEGF elevated; M-protein; polyneuropathy | 🟡 |
| 12 | Anticoagulant/Antiplatelet | ✅ | ✗ | — | Drug history; INR elevated | 🟡 |
| 13 | Cocaine Nasal Damage | ✅ | ✗ | — | Septal perforation; social history | 🟡 |
| 14 | Polycythemia Vera | ✅ | ✅ (engorged vessels) | ✅ (hyperviscosity) | Hgb/HCT markedly elevated; JAK2+ | 🟡 |
| 15 | Idiopathic / Rosacea | ✅ | ✅ (actinic/rosacea) | ✅ (non-specific) | Diagnosis of exclusion; rosacea features | 🟡 |
| Test | Purpose |
|---|---|
| Genetics: ENG, ACVRL1, SMAD4 panel | Confirm HHT — positive in 85–90% of clinical HHT |
| Family history | First-degree relatives with epistaxis/telangiectasia/AVMs — autosomal dominant |
| Dermatology/ENT examination | Characterize and count telangiectasias; nasal endoscopy |
| Test | Organ | Purpose |
|---|---|---|
| CT chest with IV contrast (thin cuts) | Lung | Pulmonary AVMs — right-to-left shunting source |
| Echocardiography with agitated saline (bubble study) | Heart/Lung | Intrapulmonary or intracardiac shunting |
| MRI brain with gadolinium | Brain | Cerebral AVMs — hemorrhage/seizure risk |
| Abdominal CT or Doppler ultrasound | Liver | Hepatic AVMs → high-output failure |
| Upper endoscopy / capsule endoscopy | GI | GI telangiectasias → GI blood loss |
| CBC + iron studies | — | Iron-deficiency anemia from chronic epistaxis |
| Test | Purpose |
|---|---|
| VWF antigen + activity | Acquired VWD from high-flow AVMs |
| ANA, anti-centromere | Exclude CREST if Raynaud's present |
| LFTs + hepatitis panel | Exclude liver disease |
| CBC, JAK2 | Exclude PV if plethoric/headache-dominant |
| Blood pressure monitoring | Hypertension as epistaxis trigger |
Top 15 Differential Diagnosis for a 10-year-old male, with typical or atypical symptoms of erythematous nonurticarial rash,localized tingling,sense of skin tightness,fatigue,flu like symptoms,malaise,irritability,hyperactivity,thirst,nausea
The combination of all three clusters in a 10-year-old male points toward several critically important diagnoses — from Lyme disease with early dissemination to new-onset Type 1 diabetes, to early multiple sclerosis, to hypoglycemia, to juvenile lupus.
| Feature | Detail |
|---|---|
| Pathogen | Borrelia burgdorferi (tick-borne) |
| Rash | Erythema migrans (EM) — expanding erythematous oval/circular rash, not urticarial, with central clearing (target/bull's-eye); can be warm but not raised/itchy like urticaria; may be localized or multiple |
| Tingling/skin tightness | Classic prodromal and concurrent neurological symptoms of early Lyme — localized tingling at EM site + peripheral paresthesias from early Lyme neuroborreliosis |
| Flu-like symptoms | Fever, myalgias, arthralgias, headache — "summer flu" presentation is classic early Lyme |
| Fatigue + malaise | Prominent in early disseminated Lyme — can be profound and persistent |
| Irritability + behavioral changes | Early neurological involvement; also systemic illness effect on mood |
| Thirst | Fever-related dehydration; systemic inflammatory state |
| Nausea | Common constitutional symptom in early disseminated Lyme |
| Stage 2 (Early Disseminated) | Multiple EM lesions, facial nerve palsy (Bell's palsy), meningitis, carditis (heart block), arthritis — can all develop simultaneously |
| Key tests | ELISA for Borrelia IgM/IgG (two-tier: ELISA → confirm with Western blot); CBC (normal or mild leukocytosis); CRP/ESR |
| Treatment | Doxycycline (age ≥8) or amoxicillin (younger); early treatment prevents progression |
| Feature | Detail |
|---|---|
| Mechanism | Autoimmune destruction of β-cells → insulin deficiency → hyperglycemia → osmotic symptoms; ketone accumulation → nausea; cellular starvation → fatigue |
| Thirst (polydipsia) | Cardinal symptom — osmotic diuresis from glucosuria → dehydration → intense thirst |
| Irritability + hyperactivity | Hyperglycemia and ketosis affect CNS → mood swings, agitation, paradoxical hyperactivity before lethargy; hypoglycemia episodes also cause irritability |
| Fatigue + malaise | Cellular energy starvation despite high blood glucose |
| Nausea | Ketone accumulation → nausea/vomiting → DKA if untreated |
| Flu-like presentation | Prodrome of T1DM onset often misidentified as viral illness; weight loss over weeks, polydipsia, polyuria |
| Rash and tingling | Hyperglycemia-induced neuropathy can cause paresthesias even at onset; erythematous rash can occur from: (a) eruptive xanthomas (hypertriglyceridemia in DKA), (b) necrobiosis lipoidica diabeticorum (early), (c) skin tightening from dehydration and interstitial fluid shifts |
| Peak age | 10–14 years — T1DM peaks in this decade |
| Key tests | Random blood glucose (>200 mg/dL with symptoms = diagnostic), HbA1c, urine glucose/ketones, islet autoantibodies (GAD65, IA-2, ZnT8, ICA), venous blood gas (if DKA suspected) |
| Feature | Detail |
|---|---|
| Mechanism | Low blood glucose → catecholamine surge (epinephrine response) → anxiety, irritability, hyperactivity, diaphoresis, tingling, skin flushing; CNS glucose deprivation → fatigue, nausea, confusion |
| Erythematous rash | Catecholamine-mediated flushing → erythematous, non-urticarial flush; skin feels tight/hot |
| Tingling | Neurogenic symptoms from acute hypoglycemia — perioral tingling, finger paresthesias |
| Thirst | Stress response; also from excessive fluid loss with adrenergic activation |
| Causes in a 10-year-old | Reactive hypoglycemia (post-carbohydrate meal), insulinoma (rare), Beckwith-Wiedemann syndrome, ketotic hypoglycemia of childhood, early T1DM with erratic dosing |
| Key tests | Whipple's triad — (1) symptoms with low blood glucose, (2) BG <70 mg/dL, (3) symptom resolution with glucose administration; fasting glucose, insulin level, C-peptide, IGF-2 |
| Feature | Detail |
|---|---|
| Roseola (HHV-6/7) | High fever → abrupt resolution → rash appears; skin feels warm/tight; usually younger children but HHV-6 can occur at 10 |
| Erythema infectiosum (Fifth Disease — Parvovirus B19) | "Slapped cheek" rash; lacy erythematous rash on trunk/extremities; non-urticarial; preceded by flu-like prodrome (fever, malaise, myalgia); joint pain; common in school-age children |
| EBV (mononucleosis) | Erythematous maculopapular rash (especially if given amoxicillin); fatigue, malaise, sore throat, lymphadenopathy |
| Tingling | Parvovirus B19 can cause paresthesias from vasculitic component; EBV from cranial nerve involvement |
| Thirst + nausea | Constitutional viral illness |
| Key tests | Parvovirus B19 IgM/IgG, EBV VCA IgM, HHV-6 serology, CBC (lymphocytosis, atypical lymphs), monospot |
| Feature | Detail |
|---|---|
| Rash | Erythematous, non-urticarial — malar (butterfly) rash (cheeks/nose, non-scarring), photosensitive rash on sun-exposed areas, skin tightness from dermal inflammation |
| Tingling | Lupus neuropathy/vasculitis → localized paresthesias; Raynaud's phenomenon |
| Neuropsychiatric SLE | Irritability, hyperactivity, mood changes, cognitive symptoms — NPSLE can be the presenting feature in children before classic organ manifestations appear |
| Thirst | Lupus nephritis → proteinuria/sodium wasting → polydipsia; also corticosteroid side effect |
| Flu-like symptoms + fatigue | Constitutional lupus activity; fevers, arthralgias, myalgias |
| Nausea | Lupus enteritis, serositis, hepatitis |
| Peak age | jSLE most commonly onset 10–15 years; more severe than adult-onset; males less common but not rare |
| Key tests | ANA (high titer ≥1:160), anti-dsDNA, anti-Smith, complement (C3/C4 low), urinalysis (proteinuria, casts), CBC (cytopenia), AntiphospholipidAb |
| Feature | Detail |
|---|---|
| Bannwarth's syndrome | Lyme radiculopathy — intense, migratory paresthesias/tingling along dermatomal distribution; skin feels hypersensitive/tight |
| Behavioral changes | Irritability, mood lability, hyperactivity — well-documented in pediatric Lyme neuroborreliosis |
| Meningitis component | Headache, photophobia, neck stiffness, nausea — can mimic aseptic meningitis |
| Rash | Multiple secondary EM lesions at disseminated stage; erythematous, non-urticarial, expanding |
| Key tests | Lyme serology (two-tier), CSF (if meningeal signs: lymphocytic pleocytosis, elevated protein, Lyme CSF antibodies), MRI brain/spine |
| Feature | Detail |
|---|---|
| Rash | Starts wrists/ankles → spreads centrally; macular → maculopapular → petechial; initially erythematous, non-urticarial; fever precedes rash by 2–4 days |
| Tingling/skin tightness | Perilesional burning/tingling from vasculitic endothelial injury |
| Flu-like symptoms | Severe headache, high fever, myalgias, malaise — "the great imitator" |
| Neurological | Confusion, irritability, lethargy — CNS vasculitis |
| Danger | RMSF without early treatment (within 5 days) carries 20–30% mortality; doxycycline is treatment of choice even in children |
| Nausea | Common constitutional feature |
| Key tests | Rickettsia rickettsii IgM/IgG serology (retrospective), skin biopsy + immunofluorescence (most rapid confirmation), CBC (thrombocytopenia, leukopenia), LFTs |
| Feature | Detail |
|---|---|
| Rash | Heliotrope rash (violaceous, non-urticarial periorbital rash); Gottron's papules (erythematous raised papules on knuckles/extensor surfaces); V-sign (chest), shawl sign (upper back) |
| Skin features | Calcinosis cutis (calcium deposits under skin → skin tightness and firmness), nailfold capillary dilation, skin feels indurated/tight |
| Tingling | Nailfold vasculopathy → localized paresthesias; myositis-related proprioceptive changes |
| Fatigue + malaise | Profound muscle weakness + systemic inflammation |
| Irritability | Pain from muscle inflammation; especially with ambulation |
| Nausea | GI vasculopathy (dysphagia, abdominal pain) |
| Key tests | CK (elevated), aldolase, LDH, AST; MRI muscles (edema); ANA, anti-MDA-5, anti-Jo-1; muscle biopsy |
| Feature | Detail |
|---|---|
| Dermatitis herpetiformis (DH) | Intensely pruritic erythematous papulovesicular rash on extensor surfaces (elbows, knees, buttocks); associated with celiac but can be non-urticarial and intensely burning/tingling |
| Tingling/burning | DH skin lesions have intense burning, tingling sensations before rash appears — classic |
| Gluten ataxia | Neurological celiac → ataxia, peripheral tingling/neuropathy, balance issues |
| Fatigue + malaise | Malabsorption → nutrient deficiencies (iron, B12, folate, D) → profound fatigue |
| Irritability + behavioral | Iron-deficiency anemia + B12 deficiency → mood changes, irritability, poor concentration |
| Thirst + nausea | Malabsorption-related dehydration; abdominal symptoms |
| Key tests | tTG-IgA + total IgA, EMA IgA, deamidated gliadin peptide IgG, skin biopsy (DH: granular IgA deposits in dermal papillae by immunofluorescence) |
| Feature | Detail |
|---|---|
| Rash | Sandpaper-textured erythematous rash starting trunk → spreads; Pastia's lines (petechiae in skin folds); tongue: strawberry tongue; perioral pallor |
| Skin tightness | Rash feels diffusely tight; desquamation follows (peeling hands/feet) |
| Tingling | Cutaneous hypersensitivity from streptococcal toxin-mediated vasodilation |
| Flu-like + nausea | Fever, sore throat, headache, vomiting, malaise |
| Irritability | Systemic toxin effect + painful pharyngitis |
| Key tests | Rapid strep test, throat culture, ASO titer, CBC (leukocytosis) |
| Feature | Detail |
|---|---|
| Mechanism | Demyelination of CNS pathways → sensory disturbances (tingling, numbness, skin tightness feeling), fatigue, cognitive changes |
| Presenting symptoms | Optic neuritis (visual blurring, pain with eye movement), paresthesias/tingling (localized, dermatomal), fatigue, behavioral changes, ataxia |
| Rash connection | No direct rash in MS, but preceding viral illness (flu-like prodrome) + localized tingling + skin tightness strongly suggests early demyelinating lesion; systemic lupus can mimic and must be excluded |
| Irritability/hyperactivity | Cognitive and behavioral changes are early pediatric MS manifestations |
| Key tests | MRI brain + spine with gadolinium (white matter plaques), VEPs, CSF (oligoclonal bands, elevated IgG index), ANA (exclude lupus) |
| Feature | Detail |
|---|---|
| Skin findings | Dry, slightly erythematous skin; myxedematous infiltration → skin feels tight, indurated; facial/periorbital puffiness |
| Tingling | Peripheral neuropathy from hypothyroidism; carpal tunnel equivalent in children |
| Fatigue + malaise | Profound; often first symptom |
| Irritability | Mood lability, depression, irritability from thyroid hormone deficiency effect on CNS |
| Thirst | Hypothyroidism can cause SIADH → free water retention, but concurrent dehydration perception |
| Nausea | GI dysmotility from hypothyroidism |
| Key tests | TSH (elevated), free T4 (low), anti-TPO antibody, anti-thyroglobulin, thyroid ultrasound |
| Feature | Detail |
|---|---|
| Mechanism | T-cell mediated (Type IV) hypersensitivity → morbilliform (non-urticarial) erythematous rash + constitutional symptoms |
| Common triggers | Antibiotics (amoxicillin, sulfonamides), NSAIDs, vaccines (days after administration), anticonvulsants |
| Rash features | Morbilliform — symmetric, erythematous, non-urticarial, maculopapular; can have localized tingling/burning |
| Systemic symptoms | Fever, malaise, fatigue, nausea, lymphadenopathy (serum sickness-like reaction) |
| DRESS syndrome | Drug Reaction with Eosinophilia and Systemic Symptoms — severe form; fever, rash, lymphadenopathy, organ involvement |
| Key tests | Medication/vaccination history (timing critical), CBC (eosinophilia), LFTs, patch testing, skin biopsy |
| Feature | Detail |
|---|---|
| Rash | Classic salmon-colored, evanescent, non-urticarial maculopapular rash appearing with fever spikes, disappearing when fever breaks — non-pruritic |
| Constitutional | High-spiking quotidian fever, malaise, fatigue, myalgias |
| Irritability + malaise | Active systemic inflammation; serositis (pleuritis, pericarditis, peritonitis) → nausea |
| Tingling | Neuropathic symptoms less common; joint pain/tightness peri-articular |
| Thirst | Fever-related fluid loss |
| Key tests | Ferritin (very high — >10,000 in systemic JIA), CBC (leukocytosis, anemia), ESR/CRP markedly elevated, ANA (usually negative in systemic JIA), rheumatoid factor (negative) |
| Feature | Detail |
|---|---|
| Mechanism | Anxiety/panic → hyperventilation → respiratory alkalosis → perioral/peripheral tingling, skin flushing (non-urticarial erythema), skin tightness sensation, nausea |
| Tingling | Hyperventilation-induced hypocapnia → localized paresthesias (classic perioral, hands, feet) |
| Skin tightness | Chest wall tightening + cutaneous vasoconstriction/flushing → skin feels tight |
| Hyperactivity + irritability | Anxiety and ADHD are common comorbidities; acute anxiety attacks manifest as hyperactivity |
| Flu-like symptoms | Stress-related immune activation → fatigue, malaise, body aches |
| Thirst | Hyperventilation → dehydration; adrenergic activation → dry mouth |
| Diagnosis of exclusion | All organic causes must be excluded before attributing to functional/psychiatric etiology |
| Key tests | Arterial/venous blood gas (low pCO₂ during episode), normal labs (glucose, CBC, thyroid, inflammatory markers), psychiatric/psychological evaluation |
| # | Diagnosis | Rash (Non-Urticarial) | Tingling/Tightness | Fatigue/Malaise | Irritability/Hyperactivity | Thirst | Nausea | Priority |
|---|---|---|---|---|---|---|---|---|
| 1 | Lyme Disease (Early Disseminated) | ✅ Erythema migrans | ✅✅ | ✅✅ | ✅ | ✅ | ✅ | 🔴 |
| 2 | Type 1 DM (New Onset) | ✅ (metabolic/eruptive) | ✅ (neuropathic) | ✅✅ | ✅✅ | ✅✅ Cardinal | ✅ | 🔴 |
| 3 | Hypoglycemia | ✅ (adrenergic flush) | ✅✅ Perioral | ✅ | ✅✅ | ✅ | ✅ | 🔴 |
| 4 | Viral Exanthem (Parvovirus/EBV) | ✅✅ Maculopapular | ✅ (parvoviral) | ✅✅ | ✅ | ✅ | ✅ | 🔴 |
| 5 | Juvenile SLE | ✅✅ Malar/photosensitive | ✅ (vasculitis) | ✅✅ | ✅✅ NPSLE | ✅ | ✅ | 🔴 |
| 6 | Lyme Neuroborreliosis (Radiculopathy) | ✅ Multiple EM | ✅✅ Dermatomal | ✅✅ | ✅✅ | ✅ | ✅ | 🟠 |
| 7 | RMSF (Rocky Mtn Spotted Fever) | ✅✅ Petechial evolves | ✅ Vasculitic | ✅✅ | ✅ | ✅ | ✅ | 🟠 |
| 8 | Juvenile Dermatomyositis | ✅✅ Heliotrope/Gottron | ✅✅ (nailfold) | ✅✅ | ✅ | — | ✅ | 🟠 |
| 9 | Celiac / Dermatitis Herpetiformis | ✅✅ DH burning rash | ✅✅ Burning/tingling | ✅✅ | ✅ | ✅ | ✅ | 🟠 |
| 10 | Scarlet Fever | ✅✅ Sandpaper | ✅ Cutaneous hypersensitivity | ✅ | ✅ | — | ✅ | 🟠 |
| 11 | Pediatric MS (First Demyelinating) | ± (viral prodrome) | ✅✅ Dermatomal | ✅✅ | ✅ | — | — | 🟡 |
| 12 | Juvenile Hypothyroidism (Hashimoto's) | ✅ Dry/erythematous skin | ✅ Neuropathic | ✅✅ | ✅✅ | ✅ | ✅ | 🟡 |
| 13 | Drug Hypersensitivity / DRESS | ✅✅ Morbilliform | ✅ Burning | ✅ | ✅ | — | ✅ | 🟡 |
| 14 | Systemic JIA (Still's Disease) | ✅✅ Salmon evanescent | ± | ✅✅ | ✅ | ✅ | ✅ | 🟡 |
| 15 | Anxiety/Panic / FND (Functional) | ✅ Adrenergic flush | ✅✅ Hyperventilation | ✅ | ✅✅ | ✅ | ✅ | 🟡 |
| Action | Purpose |
|---|---|
| Point-of-care blood glucose | T1DM, hypoglycemia — immediate exclusion |
| Detailed rash description and location | EM (Lyme), sandpaper (scarlet fever), salmon (JIA), butterfly (lupus), DH distribution (celiac) |
| Tick exposure history | Lyme, RMSF — outdoor activity, geography, recent tick bite |
| Medication/vaccine history | Drug hypersensitivity |
| Dietary history (gluten) | Celiac disease |
| Family history (autoimmune, DM) | T1DM, lupus, celiac |
| Neurological exam | Cranial nerve palsy (Lyme), cerebellar signs (MS/Lyme), weakness (JDM) |
| Test | Purpose |
|---|---|
| Random glucose + HbA1c | T1DM |
| Lyme ELISA + Western blot (two-tier) | Lyme disease |
| CBC with differential | Leukocytosis (bacterial), lymphocytosis (viral), eosinophilia (drug), anemia (lupus/celiac) |
| ESR + CRP | Inflammatory marker screening |
| ANA | Lupus, JDM, JIA |
| TSH + free T4 | Hypothyroidism |
| tTG-IgA + total IgA | Celiac |
| Rapid strep test | Scarlet fever |
| Urinalysis | Lupus nephritis (proteinuria, casts), glucosuria (DM) |
| Test | Indication |
|---|---|
| Anti-dsDNA, C3/C4, urinalysis | If ANA positive → lupus workup |
| CK, aldolase, MRI muscles | If JDM suspected |
| Parvovirus B19 IgM, EBV VCA IgM | Viral exanthem |
| Rickettsia IgM | If petechial rash + tick exposure + high fever |
| Islet autoantibodies (GAD65, IA-2) | Confirm T1DM type |
| MRI brain + spine with gadolinium | If MS/neuroborreliosis suspected |
| Blood gas (during episode) | Hypoglycemia, hypocapnia (panic) |
| Skin biopsy (IgA DIF) | Dermatitis herpetiformis |
| Ferritin | Very elevated → systemic JIA/HLH |
Top 15 Differential Diagnosis for a 70-year-old male, with typical or atypical symptoms of unremitting epigastric pain,mild fever,erythematous papulovesicular eruptions
⚠️ The single most important question is: Are the vesicles dermatomal/segmental (T6–T10 dermatomes = epigastric) or diffuse/systemic?
- Dermatomal vesicles = Herpes Zoster virtually certain
- Diffuse/systemic papulovesicular eruption = glucagonoma (NME), dermatitis herpetiformis, bullous pemphigoid, eczema herpeticum, or systemic infection
| Feature | Detail |
|---|---|
| Mechanism | VZV latent in dorsal root ganglia since childhood varicella → reactivation (immunosenescence, age-related cellular immunity decline) → travels along sensory nerve → dermatomal skin lesion + visceral pain |
| Why at age 70 | Peak incidence of zoster: >60 years; 70-year-olds have 50% lifetime risk; immunosenescence dramatically increases reactivation risk |
| Dermatomal distribution | T6–T10 dermatomes supply the epigastric region (T6 = xiphoid; T8–T10 = upper/mid abdomen) — unilateral eruption crosses from posterior trunk to anterior epigastric area |
| Unremitting epigastric pain | Prodromal phase (2–4 days before rash): severe burning, stabbing, unremitting dermatomal pain WITHOUT rash yet — frequently misdiagnosed as peptic ulcer, cholecystitis, or cardiac disease; During rash: allodynia, hyperalgesia, constant unremitting pain |
| Erythematous papulovesicular eruptions | Erythematous base → clusters of vesicles → pustules → crusting over 7–10 days; strictly unilateral, does NOT cross midline; starts as erythematous papules then rapidly develops clear vesicles |
| Mild fever | Prodromal and acute phase fever (typically 37.5–38.5°C) — not high |
| Critical clue | Ask: Are vesicles unilateral and in a band-like distribution from back to front? YES = Zoster |
| Complications | Post-herpetic neuralgia (PHN — 30–50% at age 70); visceral zoster (gut, lung, liver involvement); zoster ophthalmicus (V1); Ramsay Hunt syndrome |
| Zoster sine herpete | Severe unremitting dermatomal pain WITHOUT rash — can mimic acute abdomen; VZV PCR from blood confirms |
| Treatment | Valacyclovir 1000 mg TID × 7 days (or acyclovir IV if severe/immunocompromised); start within 72 hours of rash onset; steroids (prednisone) reduce acute pain but not PHN |
| Prevention | Shingrix (recombinant zoster vaccine) — 90%+ effective; recommended for all ≥50 years |
⚠️ In a 70-year-old with unremitting epigastric pain + papulovesicular rash, the FIRST question in the room must be: "Does the rash stop at the midline?" If yes — this is Herpes Zoster until proven otherwise.
| Feature | Detail |
|---|---|
| Mechanism | Glucagon-secreting α-cell pancreatic neuroendocrine tumor (NET) → hyperglucagonemia → hypoaminoacidemia → necrolytic skin changes → NME |
| Necrolytic Migratory Erythema (NME) | Pathognomonic rash of glucagonoma — begins as erythematous papules → vesicles → bullae → erosions → crusting; cycles through these stages continuously; affects groin, perineum, perianal area, lower abdomen, intertriginous zones; waxes/wanes ("migratory") |
| Epigastric pain | From pancreatic tumor + hepatic metastases; unremitting; often confused with peptic ulcer |
| Fever | From superinfected NME lesions; tumor-related cytokines |
| 4 D's of glucagonoma | Dermatitis (NME), Diabetes (new-onset DM2), DVT, Depression |
| Other features | Weight loss (profound), glossitis, angular cheilitis, stomatitis, normochromic anemia, new-onset diabetes, hypoaminoacidemia |
| Age | Median diagnosis: 50–60 years; 70-year-old fits; male |
| Key tests | Serum glucagon (>500 pg/mL — often >1000 pg/mL; normal <50 pg/mL), CT abdomen/pelvis (pancreatic tail mass, liver metastases), octreotide scan, MRI, skin biopsy (NME: perivascular inflammation + epidermal necrosis in upper epidermis) |
| Treatment | Somatostatin analogues (octreotide) → rapid improvement of rash; surgical resection if resectable |
"Glucagonoma: The characteristic clinical manifestations of a skin rash (necrolytic migratory erythema), weight loss, anemia, and stomatitis..." — Harrison's Principles of Internal Medicine (22e)
"The classic necrolytic migratory erythema rash and/or new-onset diabetes mellitus in the presence of a NET." — Current Surgical Therapy (14e)
"Glucagonoma is much more rare but may present similarly perhaps also with cheilitis, glossitis, and the characteristic annular, crusted, and bullous rash necrolytic migratory erythema." — Sleisenger & Fordtran's GI and Liver Disease
| Feature | Detail |
|---|---|
| Epigastric pain | Classic severe, unremitting, radiating to back; nausea/vomiting |
| Fever | Mild to moderate in moderate-severe pancreatitis; high with pancreatic necrosis/infected necrosis |
| Cutaneous manifestations | Rare but real: Grey Turner's sign (flank ecchymosis), Cullen's sign (periumbilical ecchymosis) — hemorrhagic pancreatitis; Fat necrosis panniculitis — erythematous tender papules/nodules from subcutaneous fat saponification by circulating lipases |
| Subcutaneous fat necrosis | Erythematous to violaceous papulovesicular-appearing nodules on trunk/extremities — from lipase-mediated fat destruction; can look vesicular |
| Key tests | Lipase (>3× ULN), amylase, LFTs, triglycerides, CT abdomen (pancreatic edema, peripancreatic fat stranding, necrosis) |
| Feature | Detail |
|---|---|
| Presentation | Epigastric → RUQ pain, fever, nausea; Charcot's triad (fever + RUQ pain + jaundice) in cholangitis |
| Skin manifestations | Jaundice (not vesicular per se); prurigo-type eruptions from bile salt deposition in skin → severe pruritus → excoriated papulovesicular lesions (from scratching) |
| Elderly males | Cholecystitis is the most common surgical cause of abdominal pain in the elderly |
| Key tests | RUQ ultrasound (gallstones, gallbladder wall thickening, pericholecystic fluid), LFTs, bilirubin, CBC (leukocytosis) |
"Cholecystitis: Most common surgical cause of abdominal pain in elderly; RUQ > epigastric." — Tintinalli's Emergency Medicine
| Feature | Detail |
|---|---|
| Presentation | Severe unremitting epigastric pain; rigidity; free air on CXR (perforation); penetration into pancreas → back pain |
| Fever | Chemical peritonitis (low-grade initially) → bacterial peritonitis (high fever) |
| Rash | If patient is on NSAIDs, aspirin, or antibiotics → drug-induced morbilliform or vesicular eruption coexisting with GI ulcer disease |
| Key tests | Upright CXR (free air), CT abdomen, lipase (if penetrating into pancreas), H. pylori testing |
| Feature | Detail |
|---|---|
| Paraneoplastic eruptions | Acanthosis nigricans, sign of Leser-Trelat (eruptive seborrheic keratoses — can appear vesiculopapular initially), paraneoplastic pemphigus (mucocutaneous vesiculobullous), bazex syndrome |
| Leser-Trelat sign | Sudden eruptive appearance of multiple seborrheic keratoses — associated with internal malignancy (gastric adenocarcinoma is classic) |
| Epigastric pain | Gastric cancer → unremitting epigastric pain, early satiety, weight loss, hematemesis |
| Fever | Tumor fever; obstructive gastropathy with superinfection |
| Key tests | Upper endoscopy + biopsy (gold standard), CT chest/abdomen/pelvis, CEA, CA 19-9 |
| Feature | Detail |
|---|---|
| Mechanism | Celiac disease (gluten sensitivity) → IgA anti-transglutaminase antibodies deposited in dermal papillae → vesiculobullous eruptions |
| Rash | Intensely pruritic papulovesicular eruptions on extensor surfaces (elbows, knees, buttocks, upper back); symmetrical; NOT dermatomal |
| GI | Celiac enteropathy → malabsorption, bloating, epigastric discomfort, iron-deficiency anemia |
| Fever | With secondary bacterial superinfection; or associated celiac flare |
| Age 70 | DH can present at any age; new-onset celiac/DH in elderly is not rare |
| Key tests | Skin biopsy (granular IgA deposits in dermal papillae — pathognomonic), tTG-IgA + total IgA, small bowel biopsy |
| Feature | Detail |
|---|---|
| Mechanism | VZV reactivation with severe prodromal pain but minimal/delayed skin eruption; visceral autonomic involvement can cause nausea, abdominal cramps, bladder dysfunction |
| Clinical | Unremitting unilateral dermatomal pain mimics acute coronary syndrome, peptic ulcer, biliary colic, appendicitis |
| When rash appears | Erythematous papules appear 2–5 days later in the distribution of pain — retrospective diagnosis |
| Key tests | VZV PCR from skin lesion (or blood if sine herpete), VZV IgM; start antiviral empirically if clinical suspicion high |
| Feature | Detail |
|---|---|
| Mechanism | HSV-1/2 disseminates through disrupted skin barrier (atopic dermatitis, seborrheic dermatitis, psoriasis) → widespread vesiculopustular eruptions |
| Rash | Erythematous papulovesicular lesions, often "punched-out" erosions; can be extensive; fever, malaise, lymphadenopathy |
| Epigastric | Constitutional nausea + epigastric discomfort; HSV esophagitis (immunocompromised elderly) |
| Fever | Can be high; systemic viremia |
| Risk in elderly | Immunosenescence + chronic dermatitis background |
| Key tests | HSV PCR from lesion swab, Tzanck smear (multinucleated giant cells), viral culture |
| Feature | Detail |
|---|---|
| Mechanism | Autoantibodies (IgG) against BP180 and BP230 (basement membrane proteins) → subepidermal blistering |
| Rash | Initially: erythematous urticarial-appearing papulovesicular plaques (pre-bullous phase) → tense bullae on erythematous base; non-dermatomal, widespread (trunk, flexures, abdomen) |
| Epigastric pain | Mucous membrane involvement → esophageal bullous lesions → dysphagia, epigastric pain; abdominal skin blisters are tender |
| Fever | With secondary superinfection of bullae; or corticosteroid complications |
| Peak age | >70 years — this patient is in the highest-risk demographic |
| Key tests | Skin biopsy (subepidermal split, linear IgG/C3 at BMZ by direct immunofluorescence), BP180/BP230 antibody titers |
| Feature | Detail |
|---|---|
| Mechanism | Type IV hypersensitivity → erythematous papulovesicular rash → can progress to SJS (mucosal + skin) or TEN (widespread epidermal necrosis) |
| Rash | Morbilliform initially → papulovesicular → bullous in SJS/TEN; targetoid lesions in EM/SJS |
| Epigastric pain | Mucosal involvement of GI tract in SJS/TEN → esophagitis, gastritis, erosive enteropathy |
| Fever | Common — precedes and accompanies rash |
| Common triggers in elderly | Allopurinol (#1 in elderly), NSAIDs, sulfonamides, anticonvulsants (carbamazepine), antibiotics |
| Key tests | Medication history (timing — usually 1–3 weeks after drug initiation), skin biopsy (necrotic keratinocytes, subepidermal split), SCORTEN scoring (SJS/TEN severity) |
| Feature | Detail |
|---|---|
| Rash | Classic chickenpox — erythematous macules → papules → vesicles on erythematous base → pustules → crusting; different stages simultaneously on trunk/face; intensely pruritic |
| Epigastric | Visceral varicella involvement — hepatitis, pneumonitis, GI involvement causing pain |
| Fever | High fever coincides with rash |
| Risk | Immunocompromised (steroids, chemotherapy, hematologic malignancy) elderly seronegative individual |
| Key tests | VZV IgM, VZV PCR from vesicle fluid; LFTs (hepatitis) |
| Feature | Detail |
|---|---|
| Mechanism | Pancreatic duct disruption → enzyme leak → tracking through retroperitoneum to subcutaneous tissue → enzymatic fat necrosis → erythematous papulonodular skin lesions |
| Rash | Red-to-violaceous papulovesicular nodules (subcutaneous fat necrosis) on abdomen, flanks, lower extremities |
| Epigastric pain | Chronic/acute pancreatitis component |
| Fever | Infected pseudocyst, secondary infection |
| Key tests | CT abdomen (pseudocyst, duct disruption), amylase, lipase, skin lesion aspirate (high amylase) |
| Feature | Detail |
|---|---|
| Rash | Palpable purpura — erythematous papulovesicular → purpuric lesions on lower extremities/buttocks; can be erythematous-papulovesicular before purpuric |
| GI | IgA vasculitis GI involvement → severe crampy/epigastric abdominal pain, GI bleeding, intussusception |
| Fever | Systemic inflammation |
| Renal | IgA nephropathy → hematuria, proteinuria |
| Adult HSP | More severe and chronic than childhood form; renal involvement more common |
| Key tests | Skin biopsy (IgA deposits in vessel walls by direct immunofluorescence), urinalysis, IgA level, renal function |
| Feature | Detail |
|---|---|
| Epigastric pain | Severe, unremitting; "pain out of proportion to exam" |
| Fever | From bowel ischemia → translocation of bacteria → systemic infection |
| Skin changes | Livedo reticularis (from cholesterol emboli or malperfusion) — erythematous, lacy, non-urticarial reticulate pattern on abdomen/extremities; cholesterol crystal emboli → erythematous papulovesicular skin lesions at peripheral sites |
| Elderly male | Highest risk group for ischemic gut (atherosclerosis, AF, CHF) |
| Key tests | Lactate (elevated), CT angiography, WBC (leukocytosis) |
| # | Diagnosis | Epigastric Pain | Fever | Papulovesicular Rash | Key Distinguisher | Priority |
|---|---|---|---|---|---|---|
| 1 | Herpes Zoster (T6–T10) | ✅✅ Dermatomal/unremitting | ✅ Mild | ✅✅ Unilateral dermatomal | Midline-stopping vesicles; allodynia; age >60 | 🔴 |
| 2 | Glucagonoma (NME) | ✅✅ Tumor-related | ✅ | ✅✅ NME — migratory, crusted | Serum glucagon >500; new DM; weight loss | 🔴 |
| 3 | Acute Pancreatitis + fat necrosis | ✅✅ | ✅ | ✅ Fat necrosis panniculitis | Lipase >3× ULN; CT pancreas | 🟠 |
| 4 | Cholecystitis / Cholangitis | ✅✅ RUQ>epigastric | ✅✅ | ✅ Prurigo from jaundice | RUQ US; Charcot's triad; elevated LFTs | 🟠 |
| 5 | Perforated/Penetrating PUD | ✅✅ | ✅ | ± (drug-related) | Free air on CXR; rigidity | 🟠 |
| 6 | Gastric Cancer + Paraneoplastic | ✅✅ | ✅ | ✅ Leser-Trelat/PNP | Endoscopy; CT staging | 🟠 |
| 7 | Dermatitis Herpetiformis | ✅ GI/celiac | ✅ | ✅✅ Extensor, symmetrical | Skin biopsy IgA; tTG-IgA; gluten-free response | 🟠 |
| 8 | Zoster Sine Herpete | ✅✅ Pre-eruptive | ✅ | Delayed rash | VZV PCR; empiric antivirals | 🟠 |
| 9 | Eczema Herpeticum | ✅ (GI HSV) | ✅✅ | ✅✅ Punched-out erosions | HSV PCR; pre-existing dermatitis | 🟠 |
| 10 | Bullous Pemphigoid (Pre-bullous) | ✅ Mucosal/skin | ✅ (superinfection) | ✅✅ Urticarial → tense bullae | Skin DIF: linear IgG; BP180 Ab; age >70 | 🟠 |
| 11 | Drug Reaction / SJS / TEN | ✅ Mucosal GI | ✅✅ | ✅✅ Morbilliform → bullous | Drug history; targetoid; SCORTEN | 🟡 |
| 12 | Primary Varicella (Immunocompromised) | ✅ Visceral | ✅✅ | ✅✅ Multi-stage, widespread | Different stages simultaneously; IgM negative (immunocomp) | 🟡 |
| 13 | Pancreatic Fistula / Pseudocyst | ✅✅ | ✅ | ✅ Fat necrosis | CT: pseudocyst; high amylase in lesion | 🟡 |
| 14 | IgA Vasculitis (Adult HSP) | ✅ GI vasculitis | ✅ | ✅✅ Palpable purpura | Skin DIF: IgA vessels; urinalysis | 🟡 |
| 15 | Mesenteric Ischemia + Cholesterol Emboli | ✅✅ Out of proportion | ✅ | ✅ Livedo/cholesterol emboli | Lactate; CT angiography; blue-toe syndrome | 🟡 |
| Action | Purpose |
|---|---|
| Expose skin completely — examine rash location and distribution | Does it stop at the midline? → Zoster. Bilateral/symmetric? → DH, BP, drug. Perineal/groin/lower abdomen migratory? → NME/glucagonoma |
| Map pain to rash | Dermatome T6–T10 covers epigastrium → Zoster if concordant |
| Check for allodynia | Touch-evoked pain along rash distribution = VZV neuropathy |
| Examine oral mucosa | Vesicles/erosions = SJS, BP mucous membrane involvement |
| Full abdominal exam | Peritoneal signs (perforation), RUQ tenderness (cholecystitis), epigastric mass (pancreatic tumor) |
| Test | Purpose |
|---|---|
| VZV PCR from vesicle fluid | Herpes Zoster — fast, definitive |
| Serum glucagon | Glucagonoma (NME) — if rash is migratory/crusted |
| Lipase + amylase | Pancreatitis |
| LFTs + bilirubin + RUQ ultrasound | Biliary disease |
| CBC, CMP, CRP, ESR | Systemic inflammation markers |
| Blood glucose + HbA1c | New DM (glucagonoma clue) |
| Skin biopsy (punch) | For any persistent or diagnostic rash: DIF for BP/DH/IgA vasculitis |
| tTG-IgA + total IgA | Dermatitis herpetiformis / celiac |
| Medication review | Drug reaction / SJS |
| Test | Purpose |
|---|---|
| CT abdomen/pelvis with IV contrast | Pancreatic tumor (glucagonoma), pancreatitis, perforation, AAA, mass |
| Octreotide scan / DOTATATE PET | Pancreatic NET (glucagonoma) |
| Upper endoscopy | PUD, gastric cancer, esophageal involvement (BP/SJS) |
| Upright CXR | Free air (perforation) |
Top 15 Differential Diagnosis for a 70-year-old male, with typical or atypical symptoms of Elevated lft,Worsening fatigue,abdominal distension,peripheral edema,Past Medical History of cirrhosis,Past Medical History of anemia,elevated transaminases,elevated bilirubin,Past Medical History of hepatitis c
⚠️ The critical diagnostic question is: Is this a NEW decompensation of known cirrhosis — or has a NEW complication (HCC, SBP, portal vein thrombosis, drug toxicity) been superimposed on existing disease?
| Feature | Detail |
|---|---|
| Epidemiology | HCV cirrhosis carries a 2–8% annual incidence of HCC; cumulative 30-year risk approaches 50%; age 70 + male sex + HCV cirrhosis = highest-risk demographic |
| Presentation | Worsening fatigue, weight loss, RUQ pain, abdominal distension (tumor + worsening ascites), rapid decompensation of previously stable cirrhosis |
| LFT pattern | Elevated transaminases + rising bilirubin + worsening synthetic function (PT prolongation, low albumin) |
| Abdominal distension | From worsening ascites due to HCC-mediated portal hypertension amplification; hepatic vein invasion (Budd-Chiari-like); peritoneal carcinomatosis |
| Peripheral edema | Hypoalbuminemia (tumor + cirrhosis); inferior vena cava compression by tumor |
| Anemia | HCC → chronic disease anemia; tumor bleeding; GI blood loss |
| Key tests | AFP (alpha-fetoprotein) — elevated >400 ng/mL is highly specific for HCC in cirrhosis; however 15–40% of HCCs are AFP-negative; Multiphasic contrast-enhanced CT or MRI liver (arterial enhancement → venous washout = LI-RADS 5 = HCC); Liver ultrasound (surveillance every 6 months for all cirrhotic patients) |
| Staging | Barcelona Clinic Liver Cancer (BCLC) staging guides treatment; early-stage → resection/ablation/transplant; advanced → sorafenib/lenvatinib |
| Feature | Detail |
|---|---|
| Definition | ACLF = acute decompensation of cirrhosis + organ failure (liver, kidney, brain, coagulation, circulation, respiration) with 28-day mortality 15–56% depending on grade |
| Precipitants | Bacterial infection (SBP, UTI, pneumonia), GI hemorrhage, HCV flare, alcohol binge, drugs/hepatotoxins, portal vein thrombosis, surgery |
| Presentation | Rapid worsening: jaundice, ascites, encephalopathy, peripheral edema, fatigue, coagulopathy |
| LFTs | Elevated transaminases + markedly elevated bilirubin (often >10 mg/dL) + INR >1.5 |
| ACLF grades | Grade 1–3 based on number of organ failures; Grade 3 (3+ organ failures) = 90-day mortality >70% |
| Key tests | Child-Pugh score, MELD-Na score, CBC (pancytopenia from hypersplenism), albumin (low), INR (prolonged), BMP (AKI), blood cultures, ascitic fluid (SBP), serum ammonia |
"Jaundice and ascites, which are found in approximately 60% of patients, are more frequent in patients with severe disease... Various degrees of hepatic encephalopathy can be seen." — Sleisenger & Fordtran's GI and Liver Disease
| Feature | Detail |
|---|---|
| Mechanism | Bacterial translocation from gut (E. coli, Klebsiella, Streptococcus) → ascitic fluid → infection without identifiable intra-abdominal source |
| Presentation | Fever, abdominal pain/discomfort, worsening distension, confusion (hepatic encephalopathy trigger), clinical deterioration |
| Atypical in elderly | Up to 30% of SBP is asymptomatic or presents without fever/pain — diagnosed only on diagnostic paracentesis; this is why paracentesis is mandatory in any cirrhotic with new decompensation |
| LFT pattern | Worsening transaminases + bilirubin from infection-driven ACLF |
| Peripheral edema | Worsened by infection-driven hypoalbuminemia and inflammation |
| Diagnosis | Ascitic fluid PMN ≥250 cells/mm³ = SBP regardless of culture result (culture negative in 40%); culture + sensitivity |
| Treatment | IV cefotaxime (or ceftriaxone) + IV albumin (1.5 g/kg day 1, 1 g/kg day 3) — albumin prevents hepatorenal syndrome |
"Abdominal pain, fever, or evidence of sepsis in a person with cirrhosis and ascites should suggest the possibilities of spontaneous bacterial peritonitis or spontaneous bacteremia." — Textbook of Family Medicine
"Spontaneous bacterial peritonitis... characterized by fever, abdominal pain, and an ascitic fluid polymorphonuclear count ≥250 cells/mm³." — Schwartz's Principles of Surgery
"Patients with ascites may present with fever, altered mental status, elevated white blood cell count, abdominal pain or discomfort, and acute kidney injury, or they may present without any of these features." — Harrison's Principles of Internal Medicine (22e)
| Feature | Detail |
|---|---|
| Mechanism | Impaired hepatic detoxification of gut-derived toxins (ammonia, manganese, inflammatory cytokines) → astrocyte swelling → cerebral dysfunction |
| Presentation | Fatigue, cognitive slowing, sleep disturbances (early Grade 1) → confusion, asterixis (Grade 2) → obtundation (Grade 3) → coma (Grade 4) |
| "Worsening fatigue" | Often the earliest sign of subclinical/minimal hepatic encephalopathy — misattributed to anemia or depression |
| Precipitants | Infection (SBP), GI bleed, constipation, hypokalemia, dehydration, benzodiazepines, uremia, dietary protein excess |
| LFT pattern | Reflects underlying severity; bilirubin correlation with HE grade |
| Key tests | Serum ammonia (elevated in 90%), neuropsychological testing (number connection test), EEG (triphasic waves), CT/MRI brain (exclude structural lesion) |
| Treatment | Lactulose (titrate to 2–3 soft stools/day), rifaximin (prevents recurrence), treat precipitants |
"Hepatic encephalopathy: Sleep disorientation, confusion, coma; Asterixis, altered mentation, fetor hepaticus; Serum ammonia, blood cultures." — Goldman-Cecil Medicine
| Feature | Detail |
|---|---|
| Mechanism | Severe portal hypertension → splanchnic vasodilation → systemic underfilling → renin-angiotensin-aldosterone + sympathetic activation → renal vasoconstriction → functional AKI without intrinsic renal disease |
| HRS-AKI (Type 1) | Acute, rapidly progressive AKI (creatinine doubling to >2.5 mg/dL in <2 weeks); precipitated by SBP, GI bleed, large-volume paracentesis without albumin |
| HRS-CKD (Type 2) | Gradual creatinine elevation; refractory ascites; chronic course |
| Presentation | Oliguria, rising creatinine, worsening ascites, low urinary sodium, peripheral edema worsening from sodium retention |
| LFTs | Worsening bilirubin, transaminases from underlying ACLF |
| Key tests | BMP (creatinine, BUN), urinalysis (bland sediment, low FENa <1%), UPCR, urine sodium (<10 mEq/L), Doppler ultrasound (exclude obstruction), EXCLUDE pre-renal/intrinsic causes before HRS diagnosis |
| Treatment | Norepinephrine + albumin (first line in ICU) or terlipressin + albumin; TIPS; liver transplant (definitive) |
"The term hepatorenal syndrome (HRS) was first used in 1939 to describe acute kidney injury..." — Sleisenger & Fordtran's GI and Liver Disease
| Feature | Detail |
|---|---|
| Mechanism | Active HCV replication → ongoing hepatocellular damage → elevated transaminases + bilirubin; immunosuppression (steroids, chemotherapy, rituximab) → massive HCV reactivation |
| Presentation | Rising transaminases (AST/ALT), elevated bilirubin, worsening fatigue, jaundice, abdominal distension |
| Reactivation triggers | Immunosuppressive therapy (very common at age 70 — steroids for COPD/arthritis, rituximab for lymphoma, chemotherapy) |
| Treatment status | If patient was on/completed DAA therapy — assess for treatment failure, reinfection, or resistance-associated substitutions (RAS) |
| Key tests | HCV RNA quantitative (viral load), HCV genotype, NS5A/NS5B resistance testing, liver biopsy (if needed), ultrasound/elastography |
| Feature | Detail |
|---|---|
| Presentation | Hematemesis/melena (overt); drop in hemoglobin + worsening anemia (occult); fatigue, hypotension |
| Abdominal distension | Blood in GI tract → abdominal distension + bowel gas; portal hypertension progression; worsening ascites |
| LFT pattern | GI bleed → protein load → ammonia rise → HE; blood → elevated bilirubin from hemolysis |
| Peripheral edema | Hypovolemia → RAAS activation → sodium/water retention → edema |
| Screening endoscopy | All cirrhotic patients should have EGD to screen for varices |
| Key tests | CBC (drop in Hgb/Hct), BUN/creatinine ratio (elevated in GI bleed), coagulation panel, urgent upper endoscopy |
"Portal hypertension can lead to splenomegaly, esophageal varices, ascites, dependent edema, and pleural effusions." — Miller's Anesthesia
"Portal hypertension frequently complicates cirrhosis and presents with ascites, splenomegaly, and GI bleeding from varices (esophageal or gastric)." — Washington Manual of Medical Therapeutics
| Feature | Detail |
|---|---|
| Mechanism | Cirrhosis → hypercoagulable state (paradoxically, despite coagulopathy) + stagnant portal flow → PVT → sudden portal hypertension worsening |
| Presentation | Sudden increase in ascites, abdominal distension, variceal hemorrhage, splenomegaly worsening, abdominal pain; worsening LFTs |
| Fatigue | Anemia from splenic sequestration + portal hypertension complications |
| Key tests | Doppler ultrasound of portal vein (initial test), CT angiography (portal venous phase), coagulation workup (factor V Leiden, protein C/S, JAK2 mutation for occult myeloproliferative disease) |
| Treatment | Anticoagulation (LMWH or DOAC — controversial in cirrhosis); TIPS for selected patients |
| Feature | Detail |
|---|---|
| Mechanism | Hepatotoxic drug damages already-compromised hepatocytes → acute decompensation with elevated transaminases + bilirubin |
| Common culprits in elderly | Statins, NSAIDs, acetaminophen (even therapeutic doses in cirrhosis), antibiotics (amoxicillin-clavulanate, fluoroquinolones), antifungals, herbals/supplements |
| Acetaminophen | Cirrhotic patients have impaired glutathione reserves → toxic at lower doses; ask specifically about acetaminophen in OTC products |
| Presentation | Rising transaminases + bilirubin + fatigue + worsening ascites |
| Key tests | Detailed medication review (timing), RUCAM score, liver biopsy if unclear, drug levels (acetaminophen) |
| Feature | Detail |
|---|---|
| Mechanism | Malignant bile duct transformation (intrahepatic: elevated transaminases; hilar: obstructive jaundice) |
| Presentation | Progressive jaundice (obstructive pattern: elevated direct bilirubin, ALP >> AST/ALT), weight loss, fatigue, abdominal distension |
| CCA vs. HCC | CCA: ALP/GGT-predominant elevation; HCC: AFP elevated + arterial enhancement; both can occur in cirrhosis |
| Key tests | CA 19-9 (elevated in CCA), AFP, MRCP (biliary anatomy), CT liver, liver biopsy, ERCP (hilar CCA) |
| Feature | Detail |
|---|---|
| Mechanism | Right heart failure → elevated central venous pressure → hepatic venous congestion → centrilobular necrosis → elevated transaminases + bilirubin + cardiac ascites |
| Presentation | Peripheral edema (prominent), abdominal distension (ascites), fatigue, JVD, hepatomegaly (smooth, tender) |
| LFT pattern | Elevated AST/ALT + elevated bilirubin; ALP elevated; AST:ALT ratio often >2 |
| Distinguished from cirrhosis | Cardiac: pulsatile liver, JVD, echo shows dilated RV/elevated RVSP; cirrhosis: spider angiomata, palmar erythema, splenomegaly |
| SAAG | Cardiac ascites: SAAG ≥1.1 (same as cirrhosis); protein >2.5 g/dL (cardiac) vs <2.5 g/dL (cirrhosis) |
| Key tests | Echocardiogram (EF, RVSP, TR), BNP/NT-proBNP, Doppler hepatic veins (loss of phasicity) |
| Feature | Detail |
|---|---|
| HCV-associated nephropathy | HCV → type II mixed cryoglobulinemia → membranoproliferative glomerulonephritis (MPGN) → proteinuria → hypoalbuminemia → peripheral edema + anasarca |
| Renal involvement | HCV patients have 35–40% increased risk of CKD; cirrhosis + CKD commonly coexist |
| LFTs | Normal or elevated from underlying HCV; edema from nephrotic syndrome, not liver failure per se |
| Key tests | Urinalysis (proteinuria >3.5 g/day = nephrotic range, casts), urine PCR, BMP, cryoglobulins, complement levels, renal biopsy |
| Feature | Detail |
|---|---|
| HCV-NHL link | HCV increases B-cell NHL risk 2–3×; marginal zone lymphoma (MZL) and diffuse large B-cell lymphoma (DLBCL) are most associated |
| Presentation | Worsening fatigue, abdominal distension (splenomegaly/hepatic involvement), peripheral edema (hypoalbuminemia), elevated LFTs (liver infiltration), anemia |
| LFT pattern | Elevated transaminases from liver infiltration + bilirubin; may look like HCC decompensation |
| Key tests | CT-PET scan, LDH, uric acid, peripheral smear, bone marrow biopsy, lymph node biopsy, flow cytometry |
| Feature | Detail |
|---|---|
| Mechanism | Ethanol + HCV → synergistic hepatotoxicity → acute alcoholic hepatitis flare superimposed on cirrhosis |
| LFT pattern | AST:ALT ratio >2:1 (classic for alcoholic hepatitis), elevated GGT, elevated bilirubin |
| Presentation | Fever (low-grade), jaundice, tender hepatomegaly, worsening ascites, peripheral edema, fatigue |
| Key tests | GGT (markedly elevated), AST:ALT ratio, CDT (carbohydrate-deficient transferrin for recent alcohol use), CBC (macrocytosis), alcohol level |
| Feature | Detail |
|---|---|
| Causes | Hypersplenism (thrombocytopenia + anemia from sequestration), GI bleeding (varices, portal hypertensive gastropathy, GAVE), folate/B12 deficiency, EPO deficiency, hemolysis (spur cell anemia), AIHA (HCV-related cryoglobulinemia) |
| Spur cell anemia | End-stage cirrhosis → abnormal lipid membrane loading of RBCs → spur cells (acanthocytes) → hemolysis; extremely poor prognosis |
| Peripheral edema + ascites | Hypoalbuminemia from malnutrition + chronic disease + liver synthetic failure → fluid shifts |
| Key tests | CBC (MCV, reticulocyte count), peripheral smear (target cells, acanthocytes), direct Coombs, B12/folate, iron studies, EPO level |
| # | Diagnosis | Elevated LFTs | Fatigue | Abdominal Distension | Peripheral Edema | Priority |
|---|---|---|---|---|---|---|
| 1 | Hepatocellular Carcinoma (HCC) | ✅✅ | ✅✅ | ✅✅ (tumor/ascites) | ✅ | 🔴 |
| 2 | ACLF (Decompensated Cirrhosis) | ✅✅ | ✅✅ | ✅✅ Ascites | ✅✅ | 🔴 |
| 3 | Spontaneous Bacterial Peritonitis | ✅ | ✅✅ | ✅✅ Ascites | ✅ | 🔴 |
| 4 | Hepatic Encephalopathy | ✅ | ✅✅ Early HE | ✅ | ✅ | 🔴 |
| 5 | Hepatorenal Syndrome (HRS) | ✅✅ | ✅✅ | ✅✅ Refractory ascites | ✅✅ | 🔴 |
| 6 | HCV Reactivation/Flare | ✅✅ | ✅✅ | ✅ | ✅ | 🟠 |
| 7 | Variceal Hemorrhage | ✅ (↑bili) | ✅✅ (anemia) | ✅ | ✅ | 🟠 |
| 8 | Portal Vein Thrombosis | ✅ | ✅ | ✅✅ Acute worsening | ✅ | 🟠 |
| 9 | Drug-Induced Liver Injury (DILI) | ✅✅ | ✅✅ | ✅ | ✅ | 🟠 |
| 10 | Cholangiocarcinoma | ✅✅ Obstructive | ✅✅ | ✅ | ✅ | 🟠 |
| 11 | Cardiac Cirrhosis / Right Heart Failure | ✅✅ Congestive | ✅✅ | ✅✅ | ✅✅ JVD | 🟠 |
| 12 | HCV Nephropathy / CKD | ✅ | ✅ | ✅ | ✅✅ Nephrotic | 🟡 |
| 13 | B-Cell Lymphoma (HCV-associated) | ✅✅ | ✅✅ | ✅✅ Splenomegaly | ✅ | 🟡 |
| 14 | Alcoholic Hepatitis (superimposed) | ✅✅ AST>ALT | ✅✅ | ✅✅ | ✅ | 🟡 |
| 15 | Multifactorial Anemia | — | ✅✅ | ✅ | ✅ Hypoalbumin | 🟡 |
| Test | Purpose |
|---|---|
| Diagnostic paracentesis with cell count + culture | SBP — mandatory in ANY cirrhotic with new/worsening ascites; PMN ≥250 = SBP |
| SAAG calculation (ascitic albumin vs. serum albumin) | SAAG ≥1.1 = portal hypertension; <1.1 = non-portal cause |
| Ascitic fluid LDH, glucose, cytology | Malignant ascites (HCC/lymphoma) |
| Serum ammonia | Hepatic encephalopathy |
| Serum creatinine + urinalysis | HRS vs. ATN vs. pre-renal |
| Test | Purpose |
|---|---|
| Liver panel: AST, ALT, ALP, GGT, total/direct bilirubin, albumin | Severity of liver dysfunction; pattern (hepatocellular vs. cholestatic) |
| Coagulation: PT/INR, fibrinogen | Synthetic liver function (INR not reliably measured by DOAC assays) |
| CBC with differential | Cytopenias (hypersplenism), leukocytosis (SBP/infection) |
| BMP: creatinine, BUN, electrolytes | HRS, hyponatremia (dilutional), AKI |
| AFP (alpha-fetoprotein) | HCC screening |
| HCV RNA quantitative | Active viral replication; treatment failure |
| LDH, uric acid, CA 19-9 | Lymphoma, cholangiocarcinoma |
| Blood cultures × 2 | Bacteremia complicating SBP |
| Test | Purpose |
|---|---|
| Abdominal ultrasound with Doppler (URGENT) | Liver nodules (HCC), portal vein thrombosis (Doppler), ascites volume, spleen size |
| Multiphasic CT liver (triple-phase) or MRI liver with gadoxetate | HCC characterization (LI-RADS), portal vein thrombosis, cholangiocarcinoma |
| Upper endoscopy (EGD) | Varices (grade + treat), portal hypertensive gastropathy, GAVE |
| Echocardiogram | Right heart failure / cardiac cirrhosis |
| Chest X-ray | Hepatic hydrothorax, pleural effusion |
| Component | Calculation |
|---|---|
| MELD-Na = 3.78×ln(bilirubin) + 11.2×ln(INR) + 9.57×ln(creatinine) + 6×(5−Na) + 6.43 | MELD-Na <15 = lower priority; 15–25 = transplant evaluation; >25 = urgent transplant listing |
Top 15 Differential Diagnosis for a 2-year-old male, with typical or atypical symptoms of abdominal pain | watery diarrhea | bloody diarrhea | mild anemia